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Frailty is a condition of increased vulnerability to stressors due to age-related declines in 
physiologic reserves across neuromuscular, metabolic and immune systems. Frailty is considered a 
medical geriatric syndrome with multiple causes and contributors and it is characterized by 
diminished strength, power and endurance. In the definition of the frail phenotype a key role could 
be played by nutrition and inflammation. The aim of this PhD thesis was to screen elderlies from 
the Moli-sani Study population to identify frail individuals and evaluate a possible relation between 
frailty, mediterranean diet (MD) and inflammation. The Moli-sani Study is an ongoing, prospective, 
population based cohort of 24,325 men and women (aged ≥ 35 years) who were randomly recruited 
from the general population of the Molise region, between March 2005 and April 2010, with the 
purpose of investigating genetic and environmental risk factors in the onset of cardiovascular, 
cerebrovascular and tumor diseases. The recall phase of the Moli-sani Study started in March 2017 
and a subsample of partecipants aged ≥65 years were selected for the purpose of this PhD thesis. 
Finally, 226 elderly participants (mean age 72.7±5.5 years) attended the follow-up visit from May 
2018 to May 2019. To assess frailty, the Survey of Health, Ageing and Retirement in Europe-Frailty 
Instrument (SHARE-FI) was used. Two SHARE-FI calculators, one for women and one for men, 
were used to categorize the population studied into three categories: non-frail, prefrail and frail. 
Dietary information were collected through the European Prospective Investigation into Cancer and 
Nutrition Food Frequency Questionnaire (EPIC-FFQ). Adherence to MD was calculated using the 
Trichopoulou score. Cognitive impairment and health-related quality of life were studied using two 
questionnaires: Montreal Cognitive Assessment (MoCA) and Short Form Health Survey (SF-36). 
Biochemical markers for cardiovascular diseases (total cholesterol, HDL-cholesterol, tryglicerdides, 
glucose) were tested on serum samples. Additionally, blood inflammation and coagulation 
biomarkers were determined: high sensitive C Reactive Protein (hs-CRP), blood cell count and D-
dimers. Taking into account the inflammation biomarkers, a low-grade inflammation score 
(INFLA-score) was also calculated. The prevalence of non frail, pre-frail and frail individuals was 
78.8%, 15.9%  and 5.3%, in the Moli-sani elderly cohort, respectivelly. Pre-frail and frail categories 
were collapsed to create a dichotomous variable having just two categories: “pre-frail/frail” vs “non 
frail” individuals. Women were more pre-frail/frail than men (28.2% vs 14.7%, P=0.015). Pre-
frail/frail individuals were older than non-frail individuals (mean ±SD: 75.1±6.0 vs 72.1±5.2 years, 




There was no difference between normal and pre-frail/frail elderly people in the adherence to MD. 
However, considering participants aged 65-69 years (N=88), pre-frail/frail subjects showed a higher 
prevalence of a lower adherence to MD than non-frail elderlies (50.0% vs 21.6%, P= 0.054). There 
was no significant difference in dietary habit between pre-frail/frail and non-frail participants, 
except for legume (P=0.010), fruits and nuts consumption (P=0.047), whose consumption was 
lower in pre-frails/frails. Pre-frail/frail elderlies showed a higher cognitive impairment (MoCA test, 
mean ±SD: 22.1±4.1 vs 23.6±3.5, P=0.023) and aworse perception of physical health-related quality 
of life (SF-36 physical dimension score, mean ±SD: 41.8±7.1 vs 45±5.8, P=0.0057) than non-frails. 
Pre-frail/frail individuals had lower levels of serum total cholesterol than non-frails (mean ±SD: 
185.6±38.9 vs 210±43.8mg/dL, P=0.0004), which could be associated to higher use of lipid-
lowering drugs (43.2% vs 29%, respectively). High blood levels of hs-CRP was found in pre-
frails/frails as compared with no-frail elderly people (median (IRQ): 2.5 (1.0;4.8) vs 1.4 (0.8;3.5) 
mg/L, P=0.043). D-dimers plasma levels were also higher in pre-frails/frails compared to the non-
frails (median (IRQ): 298 (227;460) vs 254 (226;328) ng/mL, P=0.053). Pre-frails/frails showed 
higher levels of blood inflammation (hs-CRP) and coagulation (D-Dimers) biomarkers which 
confirm the coexistence of the two processes, but not of cellular inflammation biomarkers (WBC, 
platelets). These findings may be relevant to promote interventions controlling inflammatory 
pathways to achieve important improvements in the elderly population. 
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Chapter 1: Introduction  
 
1.1  Frailty in elderly people: definition and characteristics 
In the last century the average life expectancy at birth has been remarkably increased from roughly 
45 years in the early 1900s to approximately 80 years today. By 2050, over 21% of the global 
population, or two billion persons, will be over 60 years of age [1]. This will lead to an increase in 
many age-related conditions, including frailty [2]. Frailty literally expresses the property of some 
materials that, without deforming, break when they are subjected to impacts. The same word is used 
to describe the characteristics of weakness and delicacy, referring to things or people. The term 
frailty started to appear in the geriatric and gerontology literature about 50 years ago, proposed as a 
predictive model for dependency, physical and mental decline in older persons [2,3]. Prior to this, 
other terms such as chronic sick, debilitated, disabled, sedentary institutionalized, incapacitated, or 
functionally dependent elderly were used to describe older person at risk of mortality or other 
adverse outcomes [4]. In 1974, Charles F. Fahey and the Federal Council on Aging (FCA) of the 
United States introduced the term frail elderly for a special group of older adults with “physical 
debilities and emotional impairment, as well as debilitating physical and social environments” who 
needed additional attention [4-7]. By 1978, the FCA defined the frail elderly as “persons, usually 
but not always over the age of 75 who, because of an accumulation of various continuing problems, 
often require one or several supportive services in order to cope with daily life” [4]. A significant 
increase in publications about frailty has been observed since the beginning of the 1990’s. At this 
time, frailty was often defined as functional dependence for the activities of daily living, associated 
with chronic diseases. As an example, Pawlson LG [8] focused on multiple illness in frail persons, 
MacAdam M et al. [9] referred to them as “elderly with chronic conditions” and Williams FM et al. 
[10] defined them as “requiring long-term hospital care owing to chronic debilitating diseases”. 
Woodhouse KW and colleagues [11] gave the following description of frail persons in their article 
“Who are the Frail Elderly? The frail elderly are individuals, over 65 years of age, dependent on 
others for activities of daily living, and often in institutional care. They are not independently 
mobile – whilst they do not have overt cardiac, respiratory, hepatic, renal or metabolic disease, 
minor abnormalities may be revealed on laboratory investigation. They may require regular 
prescribed drug therapy. Conditions contributing to frailty commonly include Alzheimer's disease, 




In 1992, Buchner DM and Wagner EH revised the definition of frailty [12]. They defined frailty as 
a reversible condition of reduced physiologic reserve associated with decreases in physiologic 
capacity in neurologic control (indicated by diminished ability to perform complex tasks), 
mechanical performance (e.g. diminished strength), and energy metabolism (e.g. decreased aerobic 
status due to cardiac or pulmonary diseases or both). This increased attention to frailty during the 
last 30 years was accompanied by the rapid growth of different concepts and definitions of frailty. 
Most commonly, frailty is now defined as a state of decreased reserve and decline in multiple 
physiological systems that results in an increased risk of adverse outcomes such as falls, decreased 
mobility, slow recovery from any illness, reduced independence and increased hospitalization, 
disability, and death [2,13-19]. It is very important to distinguish frailty from comorbidity and 
disability, because they are often used interchangeably to identify the physically vulnerable subset 
of older adults requiring enhanced care. Recent researches supports geriatricians’ perceptions that 
these are distinct clinical entities, although interrelated, and that clinical management of each of 
these has its own unique content and challenges. Disability is defined as difficulty or dependency in 
carrying out activities essential to independent living, including essential roles, tasks needed for 
self-care and living independently in a home, and desired activities important to one’s quality of life. 
Physical disability is mostly diagnosed by self-report of difficulty in specific tasks, but objective 
and performance-based tests of function also exist. It is recommended by several organizations that 
clinicians screen for disability in self-care tasks (Activities of Daily Living, ADL) and tasks of 
household management (Instrumental Activities of Daily Living, IADL) on an annual basis in 
persons aged older than 70 years. Instead, comorbidity is the concurrent presence of two or more 
medically diagnosed diseases in the same individual, with the diagnosis of each contributing disease 
based on established and widely recognized criteria [20-22]. In this sense, the concept of 
comorbidity could be viewed as an interface between the geriatric paradigm of health and the more 
traditional medical definition of disease [22]. Frailty is distinct from, but overlapping with, both 
comorbidity and disability. In addition, both frailty and comorbidity predict disability, adjusting for 
each other; disability may well exacerbate frailty and comorbidity, and comorbid diseases may 
contribute, at least additively, to the development of frailty. Early data from the Cardiovascular 
Health Study (CHS) also suggest that the presence of disability or frailty could contribute to 
development or progression of chronic diseases, possibly through the lower activity levels 
associated with the former two conditions, or through other pathways affecting some basic 
biological mechanism essential to the maintenance of homeostasis, such as inflammation, or 
sympathetic–parasympathetic equilibrium [23-25].  
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These causal relationships provide explanation for the frequent co-occurrence of these conditions, 
and suggest the clinical importance of differentiating them so as to identify appropriate 
interventions. There are causal interrelationships that can help explain why these three entities are 
likely to co-occur. A clinical manifestation of this co-occurrence is the high likelihood of finding a 
greater proportion of frail persons among those who are disabled than among the nondisabled. This 
is supported in data from the Women’s Health and Aging Study, in which 28% of this moderately to 
severely disabled population of women aged 65 years and older living in the community were frail, 
compared to 7% of a healthier subset of older women in the CHS [26]. Despite numerous 
contemporary theories and models, the causes of frailty are not yet fully understood. Numerous 
functional tests, questionnaires and indexes to categorize frailty have been proposed. Nevertheless, 
validity, reliability and agreement, responsiveness and the interpretability for general elderly 
populations remained unclear, so that geriatricians cannot yet diagnose frailty. Most frailty models 
cover seven major domains as reported in table 1. 
 
Table 1 – The seven major domains of frailty and their operationalization. 
FRAILTY DOMAINS OPERATIONALIZATION 
1. 1. Nutritional status Body weight, appetite, Body Mass Index (BMI) 
2. Physical activity  
or mobility 
Level of physical activity, leisure time physical (group) activity, 
difficulty or needing help walking/moving in and around the house, 
gait speed 
2. 3. Strength or energy Tiredness, energy level (for example exhaustion/fatigue), lifting an 
object that weighs over 5 kg, weakness in arms and/or legs, 
performing chair stands, climbing stairs, grip strength, calf muscle 
circumference 
3. 4. Cognition and mood Memory problems, diagnosed dementia or cognitive impairment, 
depression/depressed mood, sadness, anxiety, nervousness 
4. 5. Social relations/social   
support       
Social recourses, emptiness/missing people around 
1. 6. Comorbidity Presence of different diseases, medication 





The phenotypic definition of frailty as a geriatric syndrome was first proposed by Fried LP et al. 
[2], and was tested in the CHS. A phenotype of frailty is identified by the presence of three or more 
of the following components: 
1. Shrinking: weight loss, unintentional, of ≥10 pounds in prior year or, at follow-up, of ≥5% of 
body weight in prior year (by direct measurement of weight).  
2. Weakness: grip strength in the lowest 20% at baseline, adjusted for gender and body mass index 
(BMI).  
3. Poor endurance and energy: as indicated by self-report of exhaustion. Self-reported exhaustion, 
identified by two questions from the Center for Epidemiologic Studies Depression Scale (CES-D), 
is associated with stage of exercise reached in graded exercise testing, as an indicator of VO2 max, 
and is predictive of cardiovascular disease.  
4. Slowness: the slowest 20% of the population was defined at baseline, based on time to walk 15 
feet, adjusting for gender and standing height.  
5. Low physical activity level: a weighted score of kilocalories expended per week was calculated 
at baseline, based on each participant’s report. The lowest quintile of physical activity was 
identified for each gender.  
The Fried criteria [2] revolve around the age-related loss of muscle mass and strength known as 
sarcopenia. According to recommendations by the European Working Group on Sarcopenia in 
Older People (EWGSOP), sarcopenia is a syndrome characterized by the progressive and 
generalized loss of skeletal density, muscle mass, and strength, leading to a risk of adverse 
outcomes such as physical disability, poor quality of life and death [27]. The EWGSOP 
recommends using the presence of both low muscle mass and low muscle function (strength or 
performance) for the diagnosis of sarcopenia. As shown in figure 1, weakness and low physical 
function are cornerstones for the diagnosis of sarcopenia as well as for frailty. Sarcopenia has more 
frequently been the object of research in basic science, whereas in clinical practice much more 
attention has been given to frailty [28]. However, looking more closely at the pathogenesis of both 
these conditions, we find a lot of common details [2,29]. Both sarcopenia and phenotype frailty 
have been identified as predictors of similar adverse outcomes [16,17,30]. In addition, many of the 
adverse outcomes of phenotype frailty, such as increased risk of falls and fractures, disability, and 
loss of functionality and independence are probably mediated by sarcopenia. Thus, sarcopenia is a 





















From the biomedical and clinical perspective, frailty is broadly defined as a vulnerable condition in 
which multiple bodily systems are impaired [33-34]. With increasing age, there comes some 
physical and cognitive decline, such as hearing loss, diminished bone density, and poorer memory 
[35]. Frailty differs from the natural course of ageing although its prevalence increases with age. 
Frailty is not an inevitable feature of later life. First of all, not every older adult becomes frail even 
in extreme age. Secondly, compared to other older adults, frail older people display the degradation 
of many physiological systems that are responsible for healthy adaptation to the physical, social, 
and psychological demands of life [36]. Those older adults considered frail are particularly 
vulnerable to harmful or undesirable outcomes, such as hospitalization, institutionalization, 
injurious falls, or death [37]. Thus, frailty is a better indicator for those in need of intervention for 
their health and well-being than chronological age [38]. For these reasons, frailty is related to, yet 
also distinct from, natural ageing, represents those adults at the greatest risk of adverse outcomes, 
and it is heterogeneous [39]. Clinical definitions put an emphasis on the quick and efficient 
screening of patients. These definitions use the presence of chronic disease, hospitalization, 
physical functioning measures, and other biologically based measures (e.g., weight loss or walking 
speed) to identify frailty.  
Figure 1 – Cycle of frailty hypothesized by Fried LP et al. Chroinc 
undernutrion due to an inadequate intake of protein and energy, weight 
loss and aging determines a condition of sarcopenia which results in a 
diminished strength, power, resting metablocic rate and walking of speed. 




While clinicians use a frailty classification to treat and care for older people, ageing researchers 
identify frailty to gain a better understanding of the ageing process and health experiences of older 
adults [40]. They separate and compare the different experiences of robust (i.e., not classified as 
frail) and frail older adults to determine the different factors involved (e.g., genetic factors and 
biological systems). By investigating these factors, researchers aim to identify the underlying 
mechanisms and to develop interventions for prevention, treatment, and rehabilitation of frailty. 
Alternatively, sociological and gerontological perspectives argue that frailty is socially constructed 
and influenced by sociocultural forces on healthcare practices and the meanings of the experiences 
related to frailty (e.g., disability and impairment). Due to the biomedicalization of ageing [41], 
frailty is considered a medical problem and so it falls to the healthcare community to identify and 
treat [42]. The term’s increasing use in these clinical and medical contexts is what led Kaufman SR 
(1994) to report frailty as socially constructed. Using case studies, she described how frailty is 
constructed through social interactions in a clinical setting. In these interactions, older adults’ lived 
experiences became lists of health or functioning problems (also known as deficits) and changes 
they needed to make in their lives. She proposed that frailty was a label imposed upon older people 
as a result of their interactions with the health care system and society [43]. More recently, Gilleard 
C and Higgs P (2010) have suggested that people’s beliefs about frailty are shaped by societal and 
cultural views of health and ageing [44]. They theorized a “fourth age” resulting from the 
conflicting cultural views of old age; that is, one view of ageing in which older people live active, 
disease-free lives (the third age) and one in which they are dependent and have poor health (the 
fourth age). They suggested that the biomedical perspective views frailty (termed the fourth age) as 
negative due to its associations with decline and disease. Furthermore, broader society reflects these 
views by equating terms like successful with healthy ageing. Gilleard C and Higgs P proposed that 
the term frailty refers to the social representation of a weak old person associated with a marginal 
and vulnerable population without status in Western society. Frailty, or the fourth age, hence 
represents the feared and discouraged view of ageing [44]. Research concerning older people’s own 
conceptualizations of frailty illustrates their beliefs and how these differ from biomedical models 
and include social views of ageing. By analyzing the different definitions of frailty from the Oxford 
English Dictionary, research literature, and older women’s accounts of their lived experiences, 
Grenier A and Hanley J (2007) asserted that discourses and definitions of frailty revealed not only a 
perceived association with incapacity but also one of powerlessness, with implications of blame, 





Frailty was discussed as an observable physical state, through the experience of vulnerability and 
negative social assumptions, and its associations with crisis events [45]. Supporting Grenier’s and 
Hanley’findings [45], the qualitative investigation of Dutch older adults’ (both men and women) 
meanings of frailty, by Puts et al. [46], showed that frailty was seen as a state of general physical 
impairment (commonly reflected in appearance and mobility) and disease. However, older adults 
also described frailty as a condition with delineable social and psychological ill-effects: reduced 
ability to cope with physical limitations; negative emotions (e.g., fear); impaired cognitive 
functioning; and poor social interactions [45]. These two qualitative studies show that older adults’ 
own understandings of frailty are nuanced [45,46]. Older people include social and psychological 
aspects (e.g., negative emotions, poor social interactions, and fear) in their descriptions and 
discourses of frailty. To them, frailty is not just a physical state related to ageing or physical 
weakness as some biomedical definitions imply (e.g., phenotype of frailty). In a previous qualitative 
study, Grenier A [47] considered how older women negotiate their own views and experiences of 
frailty with the biomedical or clinical conceptualizations. By interviewing older women, she found 
that older women made a strong distinction between being and feeling frail. Being frail was 
imposed on them from medical or functioning classification, while feeling frail was associated with 
emotional experiences of traumatic events (e.g., loss of a loved one), disability, or physical 
impairment (e.g. incontinence). None of the women labelled themselves as frail, but they did reflect 
on moments in their lives when they felt frail. Feeling frail was more accepted because emotions 
were regarded as temporary states and consequently did not threaten their identity. However, 
admitting to being frail would require a change in their view of who they were – an identity shift. 
This work revealed how older adults negotiate this conflict between their self-view with the 
biomedical label of being frail [47]. Within the biomedical discipline, there are two commonly-used 
conceptual models (phenotype and accumulation of deficits) of frailty. Even with the increased 
application of these two models to the study of frailty, there is little to no agreement about what 
frailty actually is or how to measure it [22,48]. The two models conceptualize frailty as a physical 
syndrome caused by an underlying condition like sarcopenia (i.e., loss of skeletal muscle mass), 
which can be measured by the Fried phenotype [2] or the frail scale [49], and as a risk state 
secondary to accumulated deficits of illnesses, functional impairments, sensory impairments, and 
symptoms measured using a Frailty Index (FI) [32,50]. Therefore, phenotypic frailty proposes to be 
distinct of disability and comorbidities, while FI counts deficits regardless of their nature. 





1.2  Determinants of frailty 
From an epidemiological point of view, a 2010 UK study investigated the prevalence of frailty 
amongst 638 community-dwelling people aged 64-74 years [51]. The frailty prevalence rate was 
8.5% for women, and 4.1% for men. The Fried investigators recorded a frailty prevalence rate of 
6.9% in a cohort of 5201 men and women aged 65 years or more. Frailty rates of 3.2%; 9.5%; and 
25.7% were recorded in age groups 65-70; 75-79; and 85-89 years respectively [2]. Frailty is self-
perpetuating; its development results in a spiral of decline that leads to greater frailty and 
consequent risk of development of disability in older age. Recently, preliminary evidence has been 
reported that social factors, including social networks and socioeconomic status may also have a 
relationship with frailty [52]. However, it remains significant uncertainty regarding the contribution 
of social vulnerability to the frailty syndrome and further work to characterise the key elements that 
comprise social vulnerability [53] and the relationship between social vulnerability and frailty is 
required. Importantly, not all older people become frail as a result of the ageing process. A 
resistance to the development of frailty and a dissociation between chronological and biological age 
is often evident in older people [54]. In a proportion of vulnerable older people, the interaction of a 
number of processes can promote the development of frailty. Gobbens JJ et al. suggest ten life 
course determinants of frailty (eg, sex, income, lifestyle, life events) and the adverse outcomes 
(disability, health care utilization, death) [55]. The core of the model is formed by physical, 
psychological, and social frailty and their associated components. These components were selected 
based on the literature study and consultation of 17 experts in the field of frailty. Social 
vulnerability and frailty multiple social vulnerability factors including neighbourhood deprivation, 
social isolation and poor socioeconomic status have been associated with important adverse health 
outcomes including depression, cognitive impairment, admission to long-term care and death [56-
58]. More recently, evidence to support an association between social vulnerability and frailty has 
been reported in two large observational studies [59,60]. In order to operationalize social 
vulnerability according to a deficit accumulation approach, investigators from the Canadian Study 
of Health and Ageing (CSHA) analysed data from 10,263 study participants aged ≥65 years. The 
social vulnerability index included items such as communication, social support, social engagement 
and socioeconomic status. Social vulnerability increased with age and was greater in women. A 
moderate correlation between frailty and social vulnerability was reported. Both frailty, identified 
using the FI, and social vulnerability independently contributed to increased risk of mortality 




A 2009 cross-sectional analysis of data from 4,818 participants in the English Longitudinal Study of 
Ageing (ELSA) identified an independent association between individual socioeconomic status, 
neighbourhood deprivation and frailty. In a multivariate analysis adjusted for important potential 
confounding variables, lower individual wealth and greater neighbourhood deprivation were 
independently associated with frailty, identified using the FI [61]. Epigenetic mechanisms regulate 
the differential expression of genes in certain cells but do not result in a change to gene sequence or 
structure. DNA methylation and histone modification are considered to be the key mechanisms 
involved in the epigenetic regulation of gene expression [62]. These mechanisms, which are 
responsive to physiological and environmental cues and demonstrate reversibility, may have 
particular importance in the determination of physical phenotype and ageing [63,64]. As epigenetic 
mechanisms are responsive to environmental cues, they provide an attractive potential link between 
environmental factors, ageing and disease [65]. Epigenetic mechanisms have been investigated in 
the post-mitotic cells of the brain and have been associated with the development of synaptic 
plasticity and memory [66]. A growing body of literature supports the presence of an association 
between epigenetics, brain ageing and cognitive impairment [67]. Although there is evidence to 
support a potential link between epigenetics and ageing, the role of epigenetics in frailty is currently 
unclear and represents an area for future research. Importantly, as DNA methylation and histone 
modification are potentially reversible, epigenetic mechanisms may represent a potential target for 
future pharmacological therapeutic intervention. In humans, the causes of premature mortality are 
rooted in demographic, medical, lifestyle, and psychosocial factors. Indeed, Thomas McKeown’s 
determinants of health framework can be applied to“hit”and recovery processes [68]. On the one 
hand, hits can be caused by the environment (e.g., being struck by lightning), individual behaviours 
(e.g., smoking), genetic susceptibility (e.g., to sepsis), and health care-relatedevents (e.g., 
iatrogenic); on the other hand, recovery processes can be facilitated by nurturing environments, 
health-promoting behaviours, genetic prorecovery factors (e.g., to neural injury), and effective 
healthcare interventions. Thus, the determinants of health are double-edged swords within the “hit” 
and recovery model of frailty [69-71]. Recently, Hoogendijk EO et al. described that all older adults 
are at risk of developing frailty, although risk levels are substantially higher among those with 
comorbidities, low socioeconomic position, poor diet, and sedentary lifestyles [72]. Dent E et al. 
suggested that lifestyle and clinical risk factors are potentially modifiable by specific interventions 


















1.3  Nutrition, Mediterranean Diet and frailty 
Nutrition is another factor closely related to the frailty syndrome; indeed, it is thought to influence 
both its etiology and treatment. Several studies have examined the association between intake of 
nutrients or nutrient biomarkers with the frail phenotype [74]. Chronic undernutrition, insufficient 
protein and energy intake lead to weight loss and sarcopenia, which may, in turn, negatively 
influence eating behavior and, thus, the nutritional status [74]. According to the definition of Fried 
et al., unintentional weight loss is a susceptibility criterion for frailty [2]. Therefore, undernutrition 
is frequent among frail populations [75,76]. Although undernutrition and frailty are two distinct 
entities, according to the studies, up to 90% of malnourished elderly people are also more 
frequently frail [75-77]. Indeed, although apparently in satisfying health due to overweight, elderly 
individuals are also likely to become sacopenic,  by losing muscle mass and strength [78]. It is 
noted in the majority of cross-sectional studies that frail participants have the lowest energy intakes 
[76,79,80]. Recent studies have shown an association between frailty and nutritional status, showing 
a close relation between nutritional status assessed by Mini Nutritional Assessment (MNA) and 
frailty [75,81]. Nutritional risk assessed by MNA was also associated with incident disability in 
elderlies [82].  
Figure 2 – Model pathway for physical frailty by Dent E et al. Several factors such as 
age-related changes, genes/environment and chronic diseases could cause frailty up to 
cause cognitive impairment, disability and mortality [73]. 
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Anorexia of aging is generally defined as a loss of appetite or reduced food intake and considered as 
a modifiable risk factor for frailty [83]. Epidemiological studies have shown that reduced caloric 
intake is associated with changes in body composition and decline of physical function in the 
elderly [84]. Low energy intake is a frequent condition in the older population. It may affect 11.3% 
of men living in the community and up to 34.1% in long term care facilities [85]. Food intake 
decreases by nearly 25% between the fourth and seventh decades of life. The decline of energy 
intake can result in a dramatic decline in muscle mass and strength, leading to weight loss and 
disability [86]. A minimum of 25 Kcal/Kg/days is required to meet the energy requirements of the 
elderly. Measured Resting Energy Expenditure (REE) has been calculated between 20 and 28 
kcal/kg/day in the elderly [87]. Vellas et al. have shown, in a ten year longitudinal study among 304 
free-living elderly, that women with energy intake below 25 kcal/kg/day were more likely to 
become frail or to die [88]. Protein intake is inversely associated with frailty, except in one study 
where the distribution of daily protein intake, rather than the quantity itself, could explain this result 
[79]. Animal or vegetable protein sources are not essential in the relationship between protein 
intake and frailty [89]. Among various factors, adequate dietary protein intake is required to 
maintain muscle mass and function, and delay sarcopenia [90]. The Health, Aging and Body 
Composition Study (Health ABC) observed, over a three years period, that healthy elderly 
volunteers in the highest quintile of protein intake lost nearly 40% less total lean mass than those in 
the lowest quintile [91]. However, this study also highlighted that even the subjects in the highest 
quintile lost muscle mass during the follow-up, suggesting that the process can only be slowed 
down but not completely prevented. Aminoacids can stimulate muscle protein synthesis (MPS). 
Most of the enhancing effects on MPS after a meal are attributed to aminoacids [92]. Dietary 
protein intake can stimulate MPS and inhibit protein breakdown both in young and elderly people 
inducing a positive protein balance [93]. Higher dose of proteins may be required because of 
different muscle protein metabolism in the elderly. Several hypotheses have been developed to 
explain the relative anabolic resistance to aminoacids. The daily requirement for dietary protein is 
defined as the minimum amount resulting in a whole body net nitrogen balance of zero [94,95]. The 
current Recommended Dietary Allowance (RDA) for protein is established at 0.8g/kg-BW/day for 
all adults [96]. However, several limitations have been discussed for nitrogen balance studies. 
Precisely measuring nitrogen intake is very difficult as well as detecting short term changes in 
muscle mass. Therefore, measures may result in underestimation of protein requirements [97]. 
Furthermore, around 15% of people older than 60 years have a protein consumption below than 
RDA [98].  
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Short-term nitrogen balance results do not suggest that requirements for total dietary proteins are 
different in younger and older healthy adults [99]. Although conflicting data are reported in the 
literature, most nutritionists agree that protein needs in the elderly should be higher than the RDA 
[100]. Insufficient protein intake also influences the decline of physical function and co-morbidities. 
These factors must be taken into account when determining protein requirements in older people. 
Higher amounts of protein intake seem to reduce the risk of adverse events and to prevent frailty. In 
the Women’s Health Initiative (WHI) observational study, after adjustment for confounders, a 20% 
increase in protein intake was associated with a 32% lower risk of frailty [101]. These observational 
studies support the idea that protein supplementation can prevent or reverse sarcopenia and frailty. 
A recent meta-analysis concluded that protein supplementation could increase not only muscle mass 
but also strength gains, in addition to strength training both in younger and older subjects [102]. 
However, longer-term trials are scarce and are needed to define optimal protein intake in the elderly 
[103]. Finally, specific recommendations published recently from the PROT-AGE Study Group for 
healthy older people indicate that to maintain muscle, elderly should have a higher average protein 
daily intake than younger people, in the range of 1.0 to 1.2 g/kg-BW/day [104]. It should be 
considered that nearly 10% of frail elderly and 35% of institutionalized elderly have an average 
protein intake below these estimates, making them major targets for interventions [105]. However, 
there is no clear evidence till date for benefits of higher protein consumption in frail elderly, and 
several studies with protein supplementation alone have failed to show improvement on muscle 
mass or function [106,107]. Probably, an excessively sedentary lifestyle – a hallmark of frailty – or 
the presence of inflammatory cytokines in frail skeletal muscle have induced a blunted response of 
muscle protein synthesis to protein ingestion [108,109]. To date, several studies have focused on 
micronutrients in relation to frailty, with a particular interest in vitamin D. Older people often suffer 
from hypovitaminosis D. Vitamin D deficiency is generally associated with poorer physical 
performances and is predictive of incident disability in community elderly people [110]. Besides 
improvement of lower extremity function, the influence of vitamin D on immunity may also be an 
important challenge in frail elderly, since vitamin D supplementation studies have shown beneficial 
effects on immune function [111]. Diet rich in n-6 and poor in n-3 polyunsaturated fatty acids 
(PUFAs) may result in a pro-inflammatory environment that may be deleterious for muscle or other 
tissues. N-6 PUFAs are a precursor of arachidonic acid which is a substrate of cyclooxygenase and 
lipooxygenase enzymes [112]. Low intake of eicosapentaenoic acid (EPA) or docosahexaenoic acid 
(DHA) is associated with poor mobility in men according to the results of a cross-sectional study 
involving 417 Japanese elderly [113].  
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Fish-oil supplementation enhanced the benefits of strength training for lower limb strength, in a 
randomized study in elderly women [112]. In the same study, a greater improvement for chair-rising 
performances was observed for the trained group supplemented with fish oil. In another 
interventional study, fish oil supplementation resulted in an improvement in walking speed in 
postmenopausal women [114]. These results suggest that fish oil supplementation has a favorable 
effect especially in addition with strength training and may represent a promising preventive 
therapeutic strategy. For other micronutrients, data from the Italian InChianti cohort, a Tuscany 
(Italy)-based prospective population study designed to investigate factors contributing to decline of 
mobility in late life, are among the most interesting: frail participants consume significantly less 
vitamin D, E, C and folate, regardless of energy consumption, than non frail participants [115]. Low 
levels of vitamin E were also associated with an increased risk of frailty over time [116,117]. In the 
Spanish study on nutrition and cardiovascular risk (Seniors-ENRICA cohort), also interested in the 
association between micronutrient intakes and the frailty risk, an analysis of more than 1,600 aged 
individuals reported that poor intake of several vitamins (B6, C, E and folates), and non-adherence 
to the recommended dietary allowances for thiamine, niacin and vitamin B6 were all independently 
associated with the frailty risk [118]. Micronutrient deficiencies are commonly observed among 
elderlies with inadequate intake of various nutrients. Such deficits were also observed for 
antioxidant trace elements such as zinc and selenium [120-126]. Frail elderly women are more 
likely to have multiple micronutrient deficiencies. In a cross sectional study of 754 women of the 
Women’s Health and Aging Study (WHAS), Michelon E et al. have observed lower serum 
concentrations especially for carotenoids, and also for vitamin B6 and folates. Furthermore, frail 
women were more likely to have at least two or more micronutrient deficiencies [127]. Carotenoid 
levels are generally considered as an indicator of fruit and vegetable intake, and may thus be 
considered as a biomarker of fruit and vegetable consumption [128-130]. Semba RD et al. have 
shown in the WHAS that women in the lowest quartile for carotenoids were 57% more likely to 
develop severe walking disability [119]. Lauretani F et al. have examined the association between 
total plasma carotenoids and changes in muscle strength over a six years follow-up in 628 
participants of the InChianti study [131]. After adjustment for confounders, volunteers with plasma 
carotenoids in the lowest quartile were at higher risk to develop lower hip or knee muscle strength. 
Mean serum carotenoids levels were also associated with mean walking speed in the WHAS. A diet 
rich in fruits and vegetables may then reduce frailty factors [132]. Vitamin E and C supplementation 
have been shown to improve antioxidant enzymes and muscle function in aged animals [133]. In the 
InChianti study, Ble A et al. found an association between low circulating levels of vitamin E and 
frailty [134].  
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From the WHAS, Bartali B et al. showed that lower vitamin C intake is independently related to 
frailty [135]. In this cohort a lower decline of physical performances assessed by Short Physical 
Performance Battery Score (SPPB) was related only to higher vitamin E blood level and not to any 
other antioxidant parameters. However, data from the WHAS study suggest inter-relationships 
between vitamin B6, B12, selenium and frailty [128]. Indeed, women in the lowest quartile of 
serum concentrations of vitamin B6, B12, and selenium, in the WHAS study, had significantly 
higher risk of disability in activities of daily living (ADL)[135]. In another cross sectional study 
involving 655 subjects, plasma vitamin C concentration was correlated with handgrip strength and 
walking speed after adjusting for confounding factors [136]. Beside these aspects related to chronic 
undernutrition or to the intake of single nutrient or micronutrient, diet quality overall seems to play 
an important role in frailty development and progression [137]. Indeed, Mediterranean diet (MD) 
adherence in the older population has been associated to a reduced risk of frailty [138-140]. 
Moreover, it has been associated with long-term effect on individual frailty markers, such as 
decrease in mobility and walking speed [141,142]. The traditional MD is an eating pattern typical of 
the Mediterranean basin. This dietary model was originally defined by the American scientist Ancel 
Keys who initially described the eating behaviors of the Mediterranean people living in Southern 
Italy. Keys was impressed by the observation that these people used to consume some specific 
foods more frequently compared to his fellows in US or to those living in the Northern countries of 
Europe [143]. The key-feature of the MD is a wide consumption of fruit and vegetables, non-
refined grains, cereals, nuts, legumes, fish, olive oil as main fat source and moderate wine 
consumption preferably during the main meals [144]. Conversely, this pattern includes low intake 
of both dairy products and meat. Traditional lifestyle of Mediterranean people was also 
characterized by moderate to intense physical exercise mainly performed during the working hours 
that, in that time, were mostly of agricultural type. Thus, MD could also have beneficial effects 
applicable to frailty, in addition to the well-known benefits on cardiovascular health and longevity 
[145-147]. Several studies, including some recently published studies, confirmed that greater 
adherence to a diet of Mediterranean-type food was associated with a lower odds/risk of frailty over 
time [148-153]. Using data from the 3-City cohort, a population-based longitudinal study of the 
relation between vascular diseases and dementia in person ≥65 years, a significant 68% decreased 
risk of developing frailty in the next 2 years was observed in a representative sample of people aged 
≥75 years, suggesting that, even at advanced ages, this eating behavior could be beneficial [154].  
The 3-City cohort study also showed that following a Mediterranean-type diet was beneficial in 
terms of disability risk.  
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These last projects emphasized the importance of this dietary pattern in the phase that precedes the 
state of disability and suggested a long-term effect of the eating habits on health [155]. Results from 
studies on MD and risk of frailty were recently included in a meta-analysis, where participants with 
the strongest adherence to this dietary pattern had a significantly decreased risk of frailty by 56% 
[156]. More recently, a report observed that the benefit of a higher adherence to the MD on 
preventing frailty was also evidentin at-risk older women from the Nurses’ Health Study suffering 
from type-2 diabetes [157]. In the participants of the InChianti Study adherence to a Mediterranean-
style diet was computed from the European Prospective Investigation into Cancer and Nutrition 
Food Frequency Questionnaire (EPIC-FFQ). Frailty was defined as having at least 2 of the 
following criteria: poor muscle strength, feeling of exhaustion, low walking speed and physical 
activity. After a 6-years follow-up, higher adherence to a Mediterranean-style diet was associated 
with lower odds of developing frailty compared with those with lower adherence. A higher 
adherence to a Mediterranean-style diet at baseline was also associated with a lower risk of low 
physical activity and walking speed but not with feelings of exhaustion and poor muscle strength 
[158]. A study by León-Muñoz LM et al. analyzed how low intake of certain micronutrients and 
protein has been associated with higher risk of frailty. Additionally, this research examined the 
association between adherence to the MD and the risk of frailty in older adults showing that an 
increased adherence to the MD decreased the risk of frailty [164]. On the contrary, Chan R et al. 
failed to find such associations [165]. MD may also be considered as a key component for healthy 
aging and preventing strategies for age related disability [159,160]. It has been shown that 
adherence to the MD had positive effects on mobility after a 9-years follow-up of 935 men and 
women aged ≥65 years [161]. High adherence to the MD was associated with a lower risk of 
developing disability. In a recent study, nutritional characteristics of MD were associated with 
frailty criteria with significant lower dietary scores in frail elderly [162]. Talegawkar SA et al. 
observed the association between a Mediterranean-style diet with the risk of frailty in community-
dwelling older persons [163]. The association between frailty and MD may be explained by several 
mechanisms. Firstly, antioxidants, consumed in large amounts in the context of the MD, have been 
found to protect from the high oxidative stress which can cause muscle atrophy and loss of muscle 
fibers [166]. In particular, polyphenols highly present in the MD might act as mediators of this 
association. So far, several intervention studies regarding frail elderly people have been published, 
most of them including both nutritional and exercise interventions, with conflicting results. 
However, none of them specifically tested the effect of MD or its polyphenol components in the 
development or progression of frailty or its main features. 
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1.4  The relation between inflammation, coagulation and frailty 
A low grade inflammatory state is common in older people and activated lymphocytes and 
monocytes of healthy older people produce greater levels of the pro-inflammatory cytokine IL-6 
[167-169]. Low-grade inflammation is a subclinical condition defined as “the chronic production, 
but at a low-grade state, of inflammatory factors” [170-172]. Low-grade inflammation does not 
come from an infection but several physiological mechanisms are involved. Concentrations of 
inflammatory factors in these conditions are overall slightly higher than in healthy populations, but 
still remain in the healthy ranges. It is therefore hard to determine whether a specific patient 
exhibits low-grade inflammation, but it can be better defined at the level of a group of patients. 
Frailty and aging in general could be associated with chronic low-grade inflammation, also referred 
to as inflammaging, i.e. a condition that epidemiological studies have found to be associated with 
age-associated diseases. [173,174]. Inflammaging is a complex biological phenomenon that still 
needs to be explored as a path of successful/unsuccessful aging. As individuals grow older, several 
stressors (poor nutrition, diseases, oxidative stress, and environmental factors) increase the 
inflammaging process leading to frailty. Indeed, in centenarians the increase of pro-inflammatory 
markers is balanced by an increase of anti-inflammatory markers, suggesting that the detrimental or 
beneficial effects of inflammaging are largely personalized [175,176] (Figure 3). Inflammation has 
an important pathogenic role in many age-related diseases, including Alzheimer's disease (AD), 
atherosclerosis, heart failure, osteoporosis and osteoarthritis [177-179]. It has also been implicated 
in the pathophysiology of sarcopenia, an important component of the frailty phenotype [180,181]. 
As mentioned previously, sarcopenia or loss of muscle mass occurs with aging and is an important 
component of the phenotype of frailty [182]. Mediators of inflammation contribute to the 
pathogenesis of sarcopenia. Although direct evidence is not yet available in humans, in certain 
animal models it is apparent that activated inflammatory pathways contribute to muscle loss after 
chemical toxin or neuronal injury. In animals in which inflammatory pathways were generally 
inhibited, muscle loss was significantly less and post-injury regeneration was enhanced [183]. In the 
Health ABC study, IL-6 and TNF-α levels in individuals aged 70 to 79 years were inversely 
associated with muscle mass as determined by computed tomography imaging and formal strength 
testing [184]. This association was present even after adjusting for anti-inflammatory drug use and 
the presence or absence of inflammatory-associated conditions. Similarly, in the InChianti Study, 
high levels of IL-6, IL-1 and C-Reactive protein (CRP) were significantly associated with poor 





















There is substantial evidence to indicate that inflammation has a key pathophysiological role in 
frailty. A large prospective cohort study involving 5,201 participants reported an association 
between CRP and incident frailty as defined by the Fried criteria [2,186]. In a multivariate analysis 
adjusted for important covariates, every standard deviation increment in baseline CRP increased the 
five year incidence of frailty by 18%. A recent UK case-control study that included 101 participants 
reported results from a multivariate analysis demonstrating that TNF-α, IL-6 and CRP were 
independently associated with increasing frailty, FI and functional status [187]. A further cross-
sectional study reported an independent association between increased white blood cell (WBC) 
counts, IL-6 and frailty in 558 older women [188]. Two additional studies that pre-dated current 
definitions of frailty reported that increased IL-6 and CRP were associated with increased risk of 
functional disability and death in community dwelling older people [189,190]. Of these, however, 
only CRP remained significant after adjusting for confounders. Finally, in the WHAS, higher WBC 
counts and IL-6 levels were independently associated with prevalent frailty [191]. Activation of the 
coagulation system and increase in procoagulant markers have been associated with the 
pathogenesis of atherosclerosis [192,193].  
 
 
Figure 3 – The role of stressors, aging, and inflammation in frailty and the effects 
of mesenchymal stem cells (MSCs). As individuals grow older, several stressors 
(poor nutrition, diseases, oxidative stress, andenvironmental factors) increase the 
inflammaging process leading to frailty. MSCs secrete several factors that block or 





However, procoagulant markers, most notably D-dimers, fibrinogen, and factor VIII also increase 
with advancing age and may, in fact, correlate better with aging than with cardiovascular disease 
[192-195]. Pieper CF and colleagues, examining 1,729 participants aged ≥70 years  in the 
Established Populations for the Epidemiological Study of the Elderly (EPESE) cohort, clearly 
demonstrated that increasing age was associated with high D-dimers levels. For example, 23% of 
the participants aged 90 to 99 years had high D-dimers levels (>600 μg/L) compared with 13% in 
the age group 80 to 89 years and 7% in the age group 70 to 79 years [196]. French investigators 
measured fibrinogen concentrations in healthy subjects aged 19 to 96 years and found levels to be 
significantly higher in participants aged more than 60 years when compared with younger subjects 
[197]. Hager K et al., examining healthy individuals across the life span, found that fibrinogen 
levels increased by 25 mg/dL per decade of life and that levels as high as 320 mg/dL were found in 
more than 80% of people aged more than 65 years [198]. Other markers of activated coagulation, 
such as plasminogen activating inhibitor-1 (PAI-1) and factor VIII, have been shown to be 
increased with age [199-201]. Thus, it is now apparent that frailty is associated with markers of 
activated coagulation in geriatric populations. For this reason, it has become apparent that both 
inflammatory and coagulation pathways are increasingly active with advancing age and to a greater 
extent in those who meet criteria for frailty. The coexistence of these factors suggests an interaction 
of inflammation and coagulation in the pathophysiology of frailty. It is known that inflammatory 
cytokines stimulate release of procoagulant factors in a wide range of cell types, and that the age-
associated increase in these cytokines may thereby account for the associated activation of 
coagulation [191] (Figure 4). However, it should be recalled that adipose tissue expression of both 
prothrombotic factors and proinflammatory cytokines is high [202]. Thus, the relative increase in 
adiposity with advancing age, and particularly with frailty, may offer some explanation for the 
inflammatory and procoagulant profiles observed. The molecular mechanisms underlying increased 
levels of inflammatory cytokines in frailty are beginning to be elucidated. More recently, an inverse 
association between adherence to MD and chronic low grade inflammation has been observed in the 
Moli-sani Study, an Italian prospective cohort of 24,325 men and women, aged  ≥35 years (see 
methods for a full description of the Moli-sani Study) [203-205]. In scientific literature there are still 
no works in which frailty is associated with MD and low-grade inflammation and coagulation. An 
apriori dietary pattern marker of foods and nutrients intakes associated with inflammation has been 
built in the Seniors-ENRICA cohort. The authors observed that the highest adherence to the Dietary 
Inflammatory index (DII) was associated with a higher risk for frailty (and slow gait speed) among 




All these observations will assume greater importance if interventions aimed at regulating 
inflammatory/coagulation pathways result in clinically important improvements, such as in physical 
































Figure 4 – Inflammation/coagulation pathway to frailty. Proinflammatory signals, 
including IL-6 and TNF-α, increase with age, as do markers of activated coagulation, 
including D-dimer, fibrinogen, PAI, and Factor VIII. To the extent that these are 
primary processes, they may contribute to a cycle of physiologic changes that, in 
composite, are described as frailty [191]. 
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1.5  Neuropsychological status and frailty 
 
Attention for psychological frailty has been growing in recent years. Several studies have shown 
that ageing is often accompanied by an increase in psychological complaints and cognitive 
disabilities. Many older persons have symptoms of depression and anxiety which greatly impede 
their daily functioning [207,208]. In addition, many elderlies are lonely [209] or feel they are losing 
control of their lives [210]. Virtually all older people are also confronted with a decline in their 
cognitive abilities. Their memory becomes less reliable, their speed of thought reduces and their 
ability to do several things at the same time diminishes. The rate of this cognitive decline varies 
enormously from individual to individual, and is closely related to psychological and physical 
health. Older persons who are depressed, for example, often have problems with their memory or 
ability to concentrate, as do people who suffer a great deal of pain or severe fatigue. Cognitive 
disabilities can have an adverse effect on day-to-day functioning and are by no means always the 
result of dementia [211,212]. Studies of frailty which have also looked at psychological factors 
suggested that the psychological domain plays an important role in the concept of frailty [213,214]. 
As people get older, their chance of developing chronic diseases and functional disabilities 
increases. In addition, their social networks often shrink and they may lose their partner. To 
maintain a good quality of life and mental well-being, people must have a way of compensating for 
lost capacities [215]. In the neuropsychological domain, depression is a key component of frailty. 
Like frailty, depression is a highly prevalent condition among older adults up to 15% [216,217] and 
an important predictor of mortality in older adults [218]. Depression significantly decreases the 
quality of life, just like frailty lowers life satisfaction [219-221]. Furthermore, analogue to the 
concept of frailty, depression is a syndromal diagnosis. Depending on the definition and 
operationalization of frailty, both syndromes partially overlap, even if frailty is defined as a purely 
physical condition. For example, physical complaints such as fatigue, weight loss and poor 
endurance, may be related to depression, to frailty or to both. Despite similarities in several 
domains, there is a lack of research into the relationship between frailty and depression. Although 
similar biological mechanisms have been hypothesized to account for both syndromes-frailty and 
depression-for example, subclinical cardiovascular disease [222,223] and inflammation [224,225], 
it is unlikely that one mechanism is largely responsible for either or both syndromes in all 
individuals. In fact, although the overlap between depression and frailty is underexplored, evidence 
to date demonstrates that they are distinct constructs that share moderate overlap (similar to frailty 
and disability).  
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For example, Mezuk et B al. [226] used confirmatory latent class analysis and found that frailty and 
depression represented distinct constructs (a three-class solution for depression and a two-class 
solution for frailty with moderate correspondence between the two). The frailty phenotype is 
undoubtedly still the topic of lively debate and, although experts agree on a more comprehensive 
definition of frailty that includes, among other things, the assessment of mental health, it is also 
important to note that there is still no consensus as to the clinical presentation of frailty for practical 
screening purposes [227,228]. Several studies have also shown frailty to be closely related to Mild 
Cognitive Impairment (MCI) in prospective study cohorts [229,230]. MCI is a syndrome defined as 
cognitive decline greater than expected for an individual's age and education level but that does not 
interfere notably with activities of daily life (ADL). Prevalence in population-based epidemiological 
studies ranges from 3% to 19% in adults older than 65 years. Some people with MCI seem to 
remain stable or return to normal over time, but more than half progress to dementia within 5 years. 
MCI can thus be regarded as a risk state for dementia, and its identification could lead to secondary 
prevention by controlling risk factors such as systolic hypertension. The amnestic subtype of MCI 
has a high risk of progression to Alzheimer Disease (AD) and other types of dementia [231]. In 
order to encourage combined research in frailty and cognitive impairment, the International 
Academy on Nutrition and Aging (IANA) and the International Association of Gerontology and 
Geriatrics (IAGG) organized an International Consensus Group (ICG) to propose the operational 
definition of cognitive frailty [232]. After the consensus was published, researchers put more 
attention on these two critical geriatric syndromes. Although the prevalence of cognitive frailty in 
the community setting is low (1.0–1.8%), it has been associated with a high risk of disability, poor 
quality of life, and death [230]. Furthermore, researchers have also found a 50-item Frailty Index 
(FI) to be significantly associated with temporal and frontal cortical atrophy, detected by 
computerized axial tomography, which indicates that frailty and cognitive decline might share 
common pathophysiological mechanisms [233-235]. All of these findings show that frailty and 
cognitive impairment are closely related to each other. However, Shimada H et al. [236] found that 
only 2.7% participants displayed overlapping frailty and cognitive impairment, with the majority of 
the subjects (97.3%) devoid of the combined syndromes. The use of frailty and cognitive 
impairment parameters in predicting mortality has previously been investigated. The results, 
however, revealed several discrepancies among various reports; some found combined physical 
frailty and cognitive function assessment to enhance the likelihood of the prediction of individual’s 
risk of death than either measurement alone, while some researchers found no statistically 
significant enhancement of the combined effect [236-241].  
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Furthermore, most participants in these studies were Caucasians and aged from 60 to 90 years. The 
characteristic of cognition or frailty among the oldest-old had been shown to be different with other 
age groups [242,243]. Thus, the role of cognitive impairment, frailty or the combination of both in 
predicting adverse outcomes need to be further classified, primarily, among the oldest-old (aged 
≥90 years) and also other races. To date, no studies have focused on only cognitive impairment or 
frailty or the two syndromes combined in predicting mortality in advance late-life, and thus the 
combined effects remain unclear in the oldest-old population. Many studies have worked within 
research and clinical settings to identify target populations with frailty and MCI [244]. Participants 
with MCI in a community cohort were described by a group of investigators from the Mayo Clinic 
in 1999, who then produced a series of diagnostic criteria [245]. A conference of international MCI 
experts then revised these criteria [246], and the National Institute on Aging (NIA) joined the 
Alzheimer’s Association (AA) to publish the new diagnostic guidelines for the AD (NIA-AA). In 
these guidelines, the workgroups identified Alzheimer's disease as a continuum with three distinct 
stages: preclinical, MCI and dementia. They also outlined the following factors for the 
identification of MCI [247]:  
 concern regarding a change in cognition; 
 impairment in one or more cognitive domains; 
 preservation of independence in functional abilities; 
 absence of dementia 
Several cross-sectional studies have reported an association between physical frailty and cognitive 
function [248,249]. In addition, longitudinal studies have revealed that a higher level of physical 
frailty is associated with an increased risk of incident AD [250] and MCI [251]. These studies 
suggest that in some older adults, physical frailty is associated with the development of MCI. Older 
adults who show signs of both physical frailty and MCI may be more likely to exhibit functional 
decline than those with either frailty or MCI. However, the combined prevalence relationship 
between frailty and MCI has not been clearly established. The associations of specific physical and 
functional impairments of frailty with MCI are also unclear. In a population-based study of 
community dwelling, elderlies in the second Singapore Longitudinal Ageing Study (SLAS-2), it 
was compared the prevalence of the physical frailty syndrome, low lean muscle mass, low muscle 
strength, slow gait speed, exhaustion, low physical activity, impaired balance, impaired gait, and 
elevated fall risk between individuals with MCI and non-MCI individuals with normal (high and 




Brigola AG et al. proposed a model of association between factors, frailty, cognitive impairment 
































Figure 5 – Model of association between factors, frailty, 
cognitive impairment and their outcomes in older adults 
by Brigola AG et al. [252]. 
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From a pathophysiological point of view, the etiology of the cognitive-frailty association appeared 
to be multifactorial and several mediators or possible pathways have been suggested such as 
hormonal and inflammatory processes, nutritional, vascular, neuropathological, and metabolic 
influences [253]. However, given that experimental evidence is lacking, other questions may 
address the underlying mechanisms and determine which is the most relevant component among the 
suggested mediators between frailty and cognition. The common consequences of aging may have 
an impact on age-related conditions such as physical frailty and cognitive decline. Aging 
mechanisms such as nutrition sensing signals, p53 activation, and subsequent telomere deletion and 
DNA damage, result in the physiological reserve declines of different organs. The long-term 
chronic stressor overload further accelerates the physiological reserve declines. Moreover, the 
different vulnerability of multiple organs, or different structures in same organ, such as brain, 
results in function-related homeostatic failure, and different phenotypes/diseases, physical frailty, or 
cognitive frailty. There is certainly the evidence for an association between frailty and cognitive 
impairment and it is desirable outlining some of the mechanisms that potentially underpin this 
relationship from brain neuropathology and hormonal dysregulation to cardiovascular risk and 
psychological factors [254]. These different mechanisms are not mutually exclusive, highlighting 




















Chapter 2: Aim of the study 
The aim of this PhD thesis, carried out in collaboration with the Department of Epidemiology and 
Prevention of the I.R.C.C.S. Neuromed, Pozzilli, Italy, in the period May 2018 - May 2019, was to 
screen the over 65 years elderly population of the Moli-sani Study to identify frail individuals and 



















Chapter 3: Materials and Methods 
3.1   The Moli-sani Study and cohort design 
The cohort of the Moli-sani Study was originally recruited between 2005 and 2010 in the Molise 
region from city hall registries by a multistage sampling. First, townships were sampled in the 
major areas by cluster sampling; then, within each township, participants aged ≥35 years were 
selected by simple random sampling. Exclusion criteria were pregnancy at the time of recruitment, 
disturbances in understanding or willingness, current multiple trauma or coma, or refusal to sign the 
informed consent. Thirty percent of subjects refused to participate; based on a short questionnaire 
on risk factors and major diseases administered by telephone, those who refused were older and had 
a higher prevalence of cardiovascular disease and cancer. Subjects (n=24,325) from 30 Molise cities 
and villages of different sizes attended either of the two recruiting centers: the Catholic University 
in Campobasso (n=19,211; 79%) and San Timoteo Hospital in Termoli (n=5,114; 21%). The 
recruitment strategies were carefully defined and standardized across the two centers. The Moli-sani 
Study was approved by the Catholic University ethical committee [256]. On 2017 an active follow-
up started at the clinics of the Epidemiology and Prevention Department of the I.R.C.C.S. 
Neuromed, Pozzilli, Molise, Italy based in Via Garibaldi 21, Campobasso, Molise, Italy, and a 
random subgroup of the Moli-sani participants were recalled to participate in the second wave 
recruitment. The study protocol of the active follow-up was approved by the Ethical Committee of 
the I.R.C.C.S. Neuromed on 29/03/2017. From May 2017 to May 2019 1,400 subjects were 
recruited. For this PhD thesis, men and women aged ≥65 years were selected among the participants 
to the re-call phase of the Moli-sani Study. From May 2018 to May 2019, 226 elderly participants 
were included in this PhD study. 
 
Moli-sani follow-up visit  
After signing the informed consent, trained research personnel took blood pressure (BP) and 
anthropometric measurements using methods standardized beforehand during preliminary training 
sessions. BP was measured by an automatic device (OMRON-HEM-FL31) [257] three times on the 
non-dominant arm and the last two values were taken as the BP [258,259]. Measurements were 





Body weight and height were measured on a standard beam balance scale with an attached ruler, in 
subjects wearing no shoes and only light indoor clothing. Trained interviewers administered 
structured questionnaires to collect personal and clinical information including socio-economic 
status, physical activity, dietary habits, physio/pathological medical history risk factors for 
cardiovascular diseases (CVD) and/or tumor, family/personal history for CVD and/or tumor and 
drug use. Blood samples for laboratory analysis were also obtained from the participants who had 
fasted overnight and had refrained from smoking for at least six hours. Part of the samples were 
aliquoted and stored in liquid nitrogen in the Neuromed Biobanking Centre at the I.R.C.C.S. 
Neuromed of Pozzilli.  
 
3.2  Frailty literature systematic  review 
To identify definition, determinants and measurement for frailty to be used in the cohort study, a 
systematic search of the literature was performed. For this purpose, PubMed database search was 
used. Search terms were broadly set as: “frailty”, “frail elderly”, “geriatric assessment/methods”, 
“frailty tests/measurement”, “determinants of frailty”, “frailty and nutrition”, “frailty and 
Mediterranean Diet”, “frailty and inflammation”, “frailty and coagulation”, “frailty, inflammation 
and coagulation”, “frailty and psychological status”, “frailty and depression”, “frailty and MCI”. 
The initial search was performed in February 2018 and all the studies about frailty were taken into 
consideration. The search was limited to English and Italian language articles. Only full research 
papers and review articles were considered. A lateral search was also performed, in which the 
citations of relevant articles were searched. Papers published before 2000 were also included if 
deemed relevant to the review. Original papers reporting studies conducted either on community 
dwelling or hospitalized/institutionalized participants (regardless of the reasons of admission) were 
eligible, provided that the findings could be extended to the general population, and not restricted to 
a segment affected by particular diseases or conditions.  
The following criteria were also included in the literature review: 
 population: aged ≥65 years 
 implementation/indicator: frailty objectively measured in either observational and cross-
sectional trials 





 critiquing of frailty measurements:  
- time taken to perform the measurement  
- specialized equipment to measure frailty (for instance, a handgrip strength dynamometer) 
- requirement for assessor training 
- validity and reliability.  
Reviews on frailty were initially consulted to determine the reliability and validity of frailty 
measurements. If no discussion of validity/reliability was included in these reviews, then relevant 
individual articles were searched.  
Papers were included if they explicitly addressed frailty, irrespective of the definition or diagnostic 
instrument used. Some reasons for exclusion were: replicated data, letters to the editor, abstract only 
publications, conference proceedings, non systematic reviews, and editorials. The Frailty of the 
elderly guidelines proposed by the Regional Health Council of the Toscana Region were also 
consulted [260]. At the end of the research, we decided to use some questionnaires, tests and 
laboratory analysis, many of them already validated and widely used by geriatric clinicians and 
researchers to study frailty from different points of view: 
1) Frailty assessment 
Survey of Health, Ageing and Retirement in Europe-Frailty Instrument (SHARE-FI)  
2) Dietary information 
European Prospective Investigation into Cancer and Nutrition – Food Frequency 
Questionnaire (EPIC-FFQ)  
3) Neuropsychological status 
Montreal Cognitive Assessment (MoCA) 
Short form health survey (SF-36)  
4) Blood inflammation and coagulation biomarkers 
Hemocromocytometric analysis with leukocyte formula 
High sensitive C-Reactive Protein (hs-CRP) 
D-dimers  








3.3  Frailty assessment  
The Survey of Health, Ageing and Retirement in Europe - Frailty Instrument (SHARE-FI) 
questionnaire by Romero-Ortuno R et al. [261], available on computer, detects the variables that, 
according to Fried et al. [2], characterize frailty and provides a quantitative sum value, using a 
specific algorithm that takes into account the gender difference. As showed in figure 6, this test, 
through different questions, allows to explore different aspects of frailty, such as fatigue, loss of 
appetite, weakness, walking difficulties and poor physical activity. The SHARE-FI was selected 
because it has sufficient construct and predictive validity, and it represents the first European 
research effort towards a common frailty language at the community level. Jamar Plus+ digital 
handgrip dynamometer was used to determine the grip strength at both hands, left and right (Figure 
7). We decided to use Jamar Plus+ dynamometer because, as reported in several studies, it is the 
most widely cited instrument and appears to be generally accepted as the gold standard for its 
precision, accuracy and reproducibility [262]. The elderly subject was made to sit with the arms and 
hands extended along a (desk). The patient is asked to grip the handle of the dynamometer and to 
tighten as hard as possible, first with the left hand and then with the right hand. For each hand two 
tests were made and the measurements that appear on the display of the dynamometer were 
collected: grip strength (kg), average between the two measures made for each hand (AVG, kg), 
standard deviations (SD, kg) and coefficient of variation (CV, kg). The highest of the four was 
selected. This variable was kept continuous.  
Two accessible via web SHARE-FI calculators (see Additional files of reference [261]), one for 
women and one for men, were used to obtain the total score and the related category frailty 










Figure 6 – SHARE-FI by Romero-Ortuno R et al. is a validated and simple instrument for 
frailty screening which evaluates various aspects such as exhaustion, diminution in desire for 
food, weakness, difficulty in moving, low physical activity. Two accessible via web calculators 
(one for women and one for men) are used to obtain the total score and the frailty category to 
which the patient belongs to [261]. 
SHARE-FI 
(Romero-Ortuno R et al., 2010) 
 
1. EXHAUSTION 
In the last month, have you had too little energy to do the things you wanted to do? 
No 
Yes 
2. WEIGHT LOSS (DIMINUITION IN DESIRE FOR FOOD) 
What has your appetite been like during this last month? 
-it has been the same as usual and/or you have been eating as usual 
-it has been less than usual and/or you have been eating less than usual 
- it has been more than usual and/or you have been eating more than usual 
The presence of the criterion was coded as 1 and its absence as 0. 
3. WEAKNESS 








Because of a health or physical problem, do you have difficulty doing one of the following 
things? (exclude problems expected to last within 3 months) 
Walking 100 meters: 
No  
Yes  
Climbing one flight of stairs without resting: 
No  
Yes 
One or two positive answers received the score of 1, and two negative answers received the 
score of 0. 
5. LOW ACTIVITY 
How often do you engage in activities that require a low or moderate level of energy such 
as gardening, cleaning the car, or doing a walk? 
More than once a week  
Once a week  
One to three times a month  


















3.4  Dietary information  
Food intake was determined by the validated Italian version of the European project investigation 
into cancer and nutrition – Food Frequency Questionnaire (EPIC-FFQ) [263,264]. The 
questionnaire, computerized with tailor-made software, allowed us to interview participants in an 
interactive way, including illustrations of sample dishes of definite sizes or by reference to standard 
portion sizes. The Nutrition Analysis of EPIC-FFQ (NAF) [264] was used to convert questionnaire 
dietary data into frequencies of consumption and average daily quantities of foods (g/day) and 
energy intake (Kcal/day). NAF was linked to the Italian food composition tables for energy 
assessment [266]. To simplify the interpretation of data and to minimize within person variations in 
intake of individual foods, 188 food items were classified into 45 predefined food groups on the 
basis of similar nutrient characteristics or culinary usage (Table 2). To study a possible relation 
between Mediterranean Diet (MD) and frailty, we evaluated the adherence to the MD by using the 
MD Score (MDS) developed by Trichopoulou et al. [265]. Briefly, scoring was calculated in a 
population free from CVD, cancer, or diabetes and was based on the intake of the following 9 
items: vegetables, legumes, fruits and nuts, dairy products, cereals, meat and meat products, fish, 
alcohol, and monounsaturated to saturated fat ratio. For most items, consumption above the study 
median received 1 point; all other intakes received 0 points. For dairy products, meat, and meat 
products, consumption below the median received 1 point. Medians were gender specific. The 
possible scores ranged between 0 and 9, the latter reflecting the maximal adherence to the MD.  
Figure 7 – Jamar Plus+ handgrip is a digital dynamometer used to determine the grip 
strength (weakness) at both hands, left and right. For each hand two tests are made and 
the measurements that appear on the display of the dynamometer are collected: grip 
strength (kg), average between the two measures made for each hand (AVG, kg), 
standard deviations (SD, kg) and coefficient of variation (CV, kg). 
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Table 2 – Food grouping used in the dietary analyses. 
Foods or food groups Food items 
Potatoes Potatoes 
Cooked vegetables Leafy vegetables, root vegetables, cabbages, onion, carrots, mushrooms, egg plants, 
artichokes, sweet peppers, spinach, pumpkins, canned vegetables in oil, picked 
vegetables 
Raw vegetables Raw leafy vegetables, raw tomatoes 
Tomatoes (cooked) Tomato sauces, tomatoes 
Legumes Lentils, beans, chickpeas, fava beans, green peas 
Fruit Apples, pears, kiwi, bananas, grapes, peaches, apricots, oranges, tangerines, plums, 
strawberries, melon, khaki, figs, cherries 
Nuts and dried fruit Peanuts, almonds, hazelnuts, walnuts, dried figs, dried dates, prune 
Olives Olives 
Milk Milk   
Yogurt Yogurt  
Fresh cheese Mozzarella, ricotta cheese, taleggio cheese, gorgonzola cheese, melted cheese slices, 
other soft cream cheese 
Seasoned cheese Fontina cheese, emmenthal, gruyere, parmesan, caciocavallo cheese, other seasoned 
cheese 
Pasta and other grains Pasta, yellow maize meal 
Rice Rice 
Bread White bread, bread with oil and other bread 
Crisp bread, rusks Breads sticks, crisp bread 
Breakfast cereals Breakfast cereals 
Salty biscuits Crackers 
Red meat Beef, pork, lamb, horse, game,  other meats 
White meat Chicken, turkey, rabbit, veal 
Processed meat Sausages, ham, bologna sausage, dried beef, salami 
Offal Liver, offal 
Canned fish Canned tuna fish and other fish 
Crustaceans, molluscs Crustaceans, molluscs 
Fish Other fish 
Egg Eggs 
Vegetables oils Seed oils (except olive oils) 
Olive oil Olive oil 
Butter Butter 
Margarines Margarines 
Animal fats Visible fat from meat, poultry skin, fat from ham 
Sugar & sweets Sugar, honey, cakes, ice cream, confections, pastry, pudding 
Fruit juices Orange juice, grapefruit juices, other fruit juices 
Soft drinks Soft drinks 
Coffee Coffee 
Tea Tea 
Other sauces Dressing sauces for pasta other than tomato sauce  
Mayonnaises Mayonnaises 
Soups Vegetable soups 
Bouillon Meat and stock-cube broth 
Snacks Vegetable quiche 
Pizza Pizza 
Wine Red wine, rosé wine, white wine 




3.5   Cognitive impairment and health-related quality of life assessment  
Montreal Cognitive Assessment (MoCA) 
The Montreal Cognitive Assessment (MoCA) was used as a rapid screening instrument for mild 
cognitive impairment (MCI). It assesses different cognitive domains: attention and concentration, 
executive functions, memory, language, visuoconstructional skills, conceptual thinking, calculations, 
and orientation [267]. Time to administer the MoCA is approximately 10 minutes. The MoCA 
evaluates different types of cognitive abilities (Figure 8). These include: 
 Visuospatial/executiveability: these two abilities are assessed through the trail-making test 
B (TMT-B), which requires to draw a line to correctly sequence alternating digits and 
numbers (1-A, 2-B, etc.) and through a task which requires to draw a copy of a cube shape. 
Clock-drawing test:the person is asked to draw a clock that reads ten past eleven. 
 Animal naming: three pictures of animals are shown and the individual is asked to name 
each one. 
 Memory and delayed recall: five words are read and the test-taker is asked to repeat them. 
They are read again and asked to repeat again. After completing other tasks, the person is 
asked to repeat each of the five words again and given a cue of the category that the word 
belongs to if they are not able to recall them without the cue.  
 Attention: the test-taker is asked to repeat a series of numbers forward and then a different 
series backwards. 
 Language abilities: this task consists of repeating two sentences correctly and then listing 
all of the words that can be recalled that begin with the letter "F". 
 Abstraction: the subject is asked to explain how two items are alike, such as a train and a 
bicycle. 
 Orientation: the test administrator asks the person to state the date, month, year, day, place, 






























Figure 8 – MoCA test protocol. Several cognitive domains are explored: 
visuospatial/executive, naming, memory, attention, language, abstraction, delayed recall 
and orientation [267]. 
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The total possible score of MoCa test is 30 points; a score of 26 or above is considered normal. The 
scoring breakdown is reported in table 3. 
 
                                Table 3 – Score for each ability evaluated in the MoCA test. 
MoCA ABILITIES MoCA SCORE (points) 
Visuospatial/executive ability 5 
Animal Naming 3 
Memory and delayed recall 5 
Attention  6 
Language  3 
Abstraction 2 
Orientation 6 
Educational level 1 point is added to the test-taker's score if he or 




Short form health survey (SF-36) 
The Short Form 36 (SF-36) was used as a self-report measure of functional health and well-being 
[268]. The SF-36 is designed to be a brief yet comprehensive measure of general health status. The 
SF-36 questionnaire consists of eight scales yielding two summary measures: physical and mental 
health. The physical health measure includes four scales of physical functioning (10 items), role-
physical (4 items), bodily pain (2 items), and general health (5 items). The mental health measure is 
composed of vitality (4 items), social functioning (2 items), role-emotional (3 items), and mental 
health (5 items). A final item, termed self-reported health transition, is answered by the subject but 
is not included in the scoring process. The SF-36 offers a choice of recall format at a standard (4 
week) or acute (1 week) time frame. Likert scales and yes/no options are used to assess function and 
well-being on this 36-item questionnaire.  
To score the SF-36, scales are standardized with an algorithm to obtain a score ranging from 0 to 
100. Higher scores indicate better health status, and a mean score of 50 has been articulated as a 
normative value for all scales. During this PhD work, since SF-36 was self-reported to the elderly 




























Figure 9 – First page of the Official Italian version SF-36 questionnaire. Through 36 
multiple questions, different aspects are investigated such as physical activity, role and 
physical health, physical pain, health in general, vitality, social activities, role and 
emotional state, mental health.[269]. 
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3.6  Blood inflammation, coagulation and CVD risk biomarkers   
Venous blood sampling and treatment before laboratory analysis 
Venous blood samples were obtained by a venipuncture using the vacutainer system between the 
hours of 7.00 and 9.00 a.m. from participants who had fasted overnight and had refrained from 
smoking for at least six hours. For hemocromocytometric analysis, an EDTA fresh tube was used. 
Inflammation, coagulation and CVD risk analytes were determined on frozen samples using the 
appropriately prepared serum or plasma, respectively:  
 to obtain serum: the blood was taken in a tube with a separating gel and left at room 
temperature for about half an hour. Subsequently it was centrifuged at 3.000 rpm for 20 
minutes, separating the serum; 
 to obtain plasma: the blood was taken using tubes containing sodium citrate 3.8% in right 
proportion (1:9), mixed by gently inverting the tube and centrifuged at 3.000 rpm for 20 
minutes at room temperature. The plasma was then separated from the corpuscular part to 
avoid alterations. 
Laboratory analysis were performed in the centralized Moli-sani laboratory using commercial 
reagents and automatic analyzers. 
 
Hemocromocytometric analysis with leukocyte formula 
Clinical relevance: hemocromocytometric analysis evaluates the cell populations in the peripheral 
blood, both in terms of quantity and quality, including red blood cells (RBC), white blood cells 
(WBC) or leukocytes and platlets (PLT). The dosage of haemoglobin (Hb) and RBC indices are 
also included. The leukocyte formula provides quantitative and qualitative information on the five 
leukocyte populations: neutrophils (N), eosinophils (E), basophils (B), lymphocytes (L) and 
monocytes (M) Sample: whole blood, EDTA  
Dosage principle: the flow cytometry-based system uses light scatter, differential WBC lysis, and 
myeloperoxidase and oxazine 750 staining to provide a complete blood cell count. A cyanide-free 
method is used to measure Hb colorimetrically 
Method: enzymatic using peroxidise 
Haematological automated cell counter: all hemocromocytometric analysis were performed using 
the same cell counter ADVIA 120 (Siemens Healthcare Diagnostics Milan, Italy) within 1 h from 
blood collection. Quality Control intraday for ADVIA 120 was performed by using three different 
levels of standards: Abn I, Abn II and Normal.  
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Coefficient of variability (CV) was 2.9%, 2.5%, and 2.6% for WBC respectively for Abn I, Abn II 
and Normal; 4.2%, 2.4%, 2.8% for PLT respectively for Abn I, Abn II and Normal; 1.6%, 1.4% and 
1.3% for RBC respectively for Abn I, Abn II and Normal 
 
High sensitive C-Reactive Protein (hs-CRP) 
Clinical relevance: protein that contributes to the activation of the complement system and to the 
acceleration of phagocytosis; it is an inflammation index 
Sample: serum, separator gel  
Dosage principle: frozen serum CRP causes the agglutination of latex particles coated with anti-
CRP antibody 
Method: immunoturbidimetric assay; wavelength = 570/750nm 
Clinical chemistry instrument: ILab ARIES Instrumentation Laboratory, Milan, Italy. CV for hs-
CRP was 7.3% 
 
D-Dimers 
Clinical relevance: D-Dimer is the degradation product of fibrin stabilized by coagulation factor 
XIIIa and therefore represents an index of fibrinolysis. Its clinical use is above all in the diagnosis 
of the exclusion of venous thrombosis and of pulmonary embolism. It can be used as a marker of 
fibrinolysis even in other clinical conditions such as the Disseminated Intravascular Coagulation 
(DIC). This analyte can be high even in other clinical conditions in which there may be 
hypercoagulability and consequently hyperfibrinolysis such as trauma, surgery, burns and tumors. A 
marked increase in its concentration occurs following pharmacological fibrinolytic treatment 
Sample: plasma, sodium citrate  
Dosage principle: D-Dimers levels were measured in a suspension of polystyrene latex particles of 
uniform size coated with a monoclonal antibody highly specific for D-Dimer domain included in 
fibrin soluble derivatives. When a plasma containing D-Dimer is mixed with the Latex Reagent and 
the Reaction Buffer, the coated latex particles agglutinate. The degree of agglutination is directly 
proportional to the concentration of D-Dimer in the sample and is determined by measuring the 
decrease of the transmitted light caused by the aggregates 
Method: turbimetric immunoassay  
Coagulation instrument: ACL9000 Instrumentation Laboratory Milan Italy. CV for D-dimer was 




Blood markers of CVD risk  
Serum lipids (total cholesterol, HDL-cholesterol, triglycerides and glucose) were assayed by 
enzymatic reaction methods using an automatic analyzer (ILab ARIES Instrumentation Laboratory, 
Milan, Italy). Quality control for lipids and glucose was obtained by a commercial standard (Ser 1 
and Ser 2). The CV were respectively 4.2% and 4.2% for blood cholesterol; 3.4% and 5.1% 
respectively for HDL-cholesterol; 4.9% and 4.4% respectively for triglycerides, 3.1% and 2.9% 
respectively for blood glucose. 
 
INFLA-score 
The low-grade inflammation score (INFLA-score) had been used previously within the Moli-sani 
cohort and allows one to evaluate the possible synergistic effects of inflammation biomarkers. 10-
tiles of each biomarker levels (CRP, WBC, platelets, G/L ratio) were generated. For all four 
components, being in the highest deciles (7 to 10) gave a score which increased from 1 to 4, while 
being in the lowest deciles (1 to 4) was negatively scored from -4 to -1. Being in the deciles 5 or 6 
got zero points. In such a way, the INFLA-score ranged from between -16 and 16 and came up as 
the sum of the four biomarkers. An increase in the score represented an increase in low-grade 
inflammation intensity. For analysis purposes, quartiles of the INFLA-score were also generated 
[270,271]. 
 
3.7  Covariate assessment  
History of cardiovascular disease (angina, myocardial infarction, revascularization procedures, 
peripheral artery disease and cerebrovascular events) was self-reported and confirmed by medical 
records and therapy. History of cancer was self-reported and confirmed by medical records. 
Hypertension, hyperlipidaemia and diabetes were defined by use of specific pharmacological 
treatment. Physical activity (PA) was assessed by a structured questionnaire (24 questions on 
working and leisure time and sport participation) and expressed as daily energy expenditure in 
metabolic equivalent task-hours. Leisure-time PA was expressed as daily energy expenditure in 
metabolic equivalent task-hours (MET-h/d) for sport, walking and gardening [272]. Height and 
weight were measured and Body Mass Index (BMI) was calculated as kg/m
2
 and then grouped into 
three categories as normal (≤25), overweight (>25<30) or obese (≥30). Waist circumferences were 
measured according to the National Heart, Lung and Blood Institute guidelines [273].  
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Household net income categories were considered as low (< 25,000 Euro/year), medium–high 
(>25,000 ≤40,000 Euro/year) and high (>40,000 Euro/year). Education level was divided into three 
categories: up to lower secondary, upper secondary and post-secondary. Subjects were classified as 
non-smokers if they had smoked less than 100 cigarettes in their lifetime or they had never smoked 
cigarettes, ex-smokers if they had smoked cigarettes in the past and had stopped smoking for at least 
1 year, and current smokers if they reported having smoked at least 100 cigarettes in their lifetime 
and still smoked or had quit smoking within the preceding year [274]. 
 
3.8  Statistical analysis  
All continuous variables were tested for normality using Shapiro’s test and were reported as means± 
standard deviation (SD). Categorical variables were reported as frequencies and percentages. 
Variables with positive skewed distribution (SHARE-FI score, triglycerides, glucose, hs-CRP, 
leucocytes, D-dimers) were natural log-transformed and were reported as median and interquartile 
range (IQR). SHARE-FI score was categorized in non-frail, pre-frail and frail separately for men 
and women, as reported by Romero-Ortuno et al. [261] (Figure 10). 
 
 















Figure 10 – Cut-offs for the SHARE-FI categorization by 




Differences in the distribution of demographic (age, sex), socioeconomic (i.e. education, income), 
clinical (i.e. history of CVD, cancer, diabetes), biochemical (i.e. blood inflammation and 
coagulation biomarkers, lipids) and dietary (i.e. MDS, food groups, macronutrients) variables 
according to frailty categories were calculated using non-parametric Wilcoxon Two-Sample Test 
(for continuous variables) and Exact Fischer test (for categorical variables) in SAS software. Two-
sided P-value <0.05 was considered as statistically significant. The data analysis was generated 
using SAS/STAT software, Version 9.4 of the SAS System for Windowsª2009. SAS Institute Inc. 
and SAS are registered trademarks of SAS Institute Inc., Cary, NC, USA. (ref: SAS Institute Inc. 

















Chapter 4: Results 
During this PhD thesis, from May 2018 to May 2019, 229 elderly subjects aged ≥65 were recruited 
during the recall phase of the Moli-sani Study at the recruitment centre of the Epidemiology and 
Prevention Department of the I.R.C.C.S. Neuromed, Pozzilli, based in Via Garibaldi 21, 
Campobasso, Molise, Italy. Finally, 226 people were analyzed because 3 subjects were excluded 
from the statistical analysis for unreliable questionnaires. We calculated the SHARE-FI score 
according to Romero-Ortuno R et al. [261] and determined distribution in the total sample (N=226). 


















The SHARE-FI score median (Interquartile Range, IQR) was the same both for men and women 
(median (IRQ): -0.43(-0.79;0.38) and -0.44 (-0.77;0.72), respectively). However, considering the 
distribution of the five components proposed by Romero-Ortuno R et al. [261], the prevalence of 
self-reported exhaustion (fatigue) was higher in women than in men (14.6% vs 4.3%, respectively; 
P=0.011). Moreover, the grip strength, determined using Jamar Plus+ digital dynamometer, was 
lower in women than in men (mean ±SD: 22.1 ± 6.1 vs 39.6 ± 8.6 Kg, respectively; P<0.0001) 
(Table 4). 
 
Figure 11 – SHARE-FI non-Gaussian distribution in 
the total sample (N=226). 
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Table 4 – SHARE-FI and its components distribution in men and women (N=226). 
 Gender  
 Women Men P value 
N (%) 110 (48.7) 116 (51.3)  
SHARE-FI score, median (IQR) -0.43 (-0.79;0.38) -0.44 (-0.77;0.72) 0.44 
SHARE-FI score Components    
Fatigue,  14.6 4.3 0.011 
Loss of appetite,  8.2 3.5 0.16 
Grip strength, Kg mean±SD 22.1±6.1 39.6±8.6 <0.0001 
Functional difficulties 10.9 17.2 0.19 
Physical activity   0.74 
hardly ever, o never 66.4 69.0  
one to three times a month 19.1 14.6  
once a week 4.5 3.5  
more than once a week 10.0 12.9  
           p value from non-parametric Wilcoxon Two-Sample Test (continuous) and Exact Fischer test (categorical)  
           Values are presented as percentages unless otherwise stated 
           IQR= Interquartile Range 
 
Using Romero-Ortuno R et al. categorization (non-frail, pre-frail and frail) [261], it was possible to 
divide the total sample (N=226) in the three above-mentioned groups. The prevalence of pre-frail 
and frail individuals was 15.9% and 5.3%, respectively. The prevalence of frail individuals resulted 
higher in women than in men (Table 5). 
 
Table 5 – SHARE-FI categorization in the total sample (N=226). 
 Non-frail Pre-frail Frail 
Total sample, N (%) 178 (78.8) 36 (15.9) 12 (5.3) 
SHARE-FI score  -0.61 (-0.82;-0.24) 1.20 (0.75;1.63) 3.51 (2.65;4.21) 
Women, N (%) 79 (71.8) 23 (20.9) 8 (7.3) 
SHARE-FI score  -0.65 (-0.89;-0.36) 0.80 (0.60;1.11) 3.06 (2.43;4.21) 
Men, N (%) 99 (85.3) 13 (11.2) 4 (3.5) 
SHARE-FI score -0.54 (-0.80;-0.07) 1.65 (1.42;2.10) 3.80 (3.36;4.38) 
                        Values are presented as median and Interquartile range unless otherwise stated 







Pre-frail and frail categories were collapsed to create a dichotomous variable having just two 
categories: pre-frail/frail vs non frail individuals. Women were more pre-frail/frail than men 
(28.2% vs 14.7%, respectively; P=0.015). The characteristics of the study population are showed in 
table 6. Pre-frail/frail individuals were older than frail individuals (mean ±SD: 75.1±6.0 vs 72.1±5.2 
years, respectively; P=0.0008). Moreover, pre-frail/frail elderly people showed a tendency towards 
lower level of education (45.8% vs 36.7%, respectively; P>0.05) and household income ≤25,000 
EUR/year (52.1% vs 41.6%, respectively; P>0.05) and a higher prevalence of history of 
cardiovascular disease (16.7% vs 10.2%, respectively; P>0.05). Pre-frail/frail elderly people 
showed a higher significant prevalence of hypertension than non fail individuals (72.9% vs 58.2%, 
respectively; P=0.068). 
 
Table 6 – Characteristics of the study sample according to frail phenotype (N=226). 
  Frail phenotype  
 Total  Non-frail Pre-frail/frail P value 
N of subjects (%) 226 (100) 178 (78.8) 48 (21.2)  
Men  51.3 55.6 35.4 0.015 
Age (years, mean±SD) 72.7±5.5 72.1±5.2 75.1±6.0 0.0008 
Educational level    0.54 
Up to lower secondary  38.7 36.7 45.8  
Upper secondary 39.6 40.7 35.4  
Postsecondary  21.8 22.6 18.8  
Household income (€/yr)    0.66 
≤25,000  43.8 41.6 52.1  
>25,000≤40,000 32.7 33.7 29.2  
>40,000 15.9 16.9 12.5  
Unknown 7.5 7.9 6.3  
Smoking status    0.31 
Non-smokers 53.1 50.6 62.5  
Current  10.6 10.7 10.4  
Former  36.3 38.7 27.1  
BMI (kg/m
2
)    0.65 
Normal weight  23.5 23.0 25.0  
Overweight  43.4 44.9 37.5  
Obesity  33.2 32.0 37.5  
History of CVD 11.6 10.2 16.7 0.21 
History of Cancer 12.5 11.9 14.6 0.63 
Diabetes 13.8 13.6 14.6 0.82 
Hypertension 61.3 58.2 72.9 0.068 
Hyperlipidaemia    0.14 
Yes  30.1 27.5 39.6  
Unknown  5.8 5.1 8.3  
                           p value from non-parametric Wilcoxon Two-Sample Test (continuous) and Exact Fischer test (categorical)  
                          Values are presented as percentages unless otherwise stated 
                          Abbreviation: CVD: cardiovascular disease 
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Table 7 shows dietary habits of the study sample according to frail phenotype. For this analysis 222 
individuals were considered, because 4 EPIC-FFQs were incomplete. There was no difference 
between normal and pre-frail/frail elderly people in the adherence to MD. However, considering the 
single MD components (food groups), we found a reduced consumption of fruits and nuts (P=0.047) 
and legumes (P=0.010) in pre-frails/frails compared to non frail individuals. 
Table 7 – Dietary habit of the study sample according to frail phenotype (N=222). 
 
 Frail phenotype  
 Non-frail Pre-frail/frail P value 
    
N of subjects (%) 177 
(79.0) 
47 (21.0)  
Mediterranean diet score (0-9) 4.5±1.7 4.2±1.8 0.25 
Mediterranean diet score, %    
Low (0-3) 27.7 34.0 0.55 
Medium (4, 5) 41.2 42.6  
High (6-9) 31.1 23.4  
Energy intake (Kcal/d) 1826±456 1766±415 0.46 
    
Food groups (g/d)    
Fruits and nuts  300±126 265±139 0.047 
Vegetables  139±52 127±58 0.41 
Legumes  32±17 25±14 0.010 
Cereals  170±66 172±49 0.74 
Fish  49±24 44±22 0.25 
MUFAs/SFAs 1.33±0.27 1.26±0.20 0.18 
Meat and meat products  75±29 78±36 0.67 
Milk and dairy products 154±103 161±84 0.44 
Moderate alcohol consumers, % 37.9 46.8 0.32 
    
Macronutrients (g/d)    
Carbohydrates  211±62 206±54 0.74 
Proteins 75±17 73±15 0.55 
Animal protein  51±13 50±13 0.63 
Vegetable protein  24±6 23±6 0.35 
Fats 71±19 68±18 0.54 
Monounsaturated FA 33.0±8 31.5±9 0.32 
Polyunsaturated FA 7.7±2.0 7.6±1.9 0.82 
Saturated FA 26±9 25±7 0.73 
Fibre  19.0±4.3 17.6±5.0 0.12 
Dietary calcium (mg/d) 893±282 859±254 0.25 
Dietary sodium (mg/d) 2024±662 1982±519 0.99 
                      Values are reported as means with standard deviation (SD) unless otherwise stated.  
                        p value from non-parametric Wilcoxon Two-Sample Test (continuous) and Exact Fischer test (categorical)  
                       Abbreviation FA: fatty acids 
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When participants aged 65-69 years, pre-frail/frail subjects had higher prevalence of a lower 
adherence to MD than non-frail elderly people (50.0% vs 21.6%, respectively; P=0.054, table 8). 
Table 8 – Mediterranean Diet and frailty in participants aged 65-69 years (N=88). 
 
 
Participants aged 65-69 yrs, 
N 88 
Frail phenotype 
Non-frail Pre-frail/frail P value 
Mediterranean diet score,%    
low 21.6 50.0 0.054 
medium 48.7 16.7  
high 29.7 33.3  
                                   p value from non-parametric Exact Fischer test (categorical)  
 
 
Pre-frail/frail elderlies showed a higher cognitive impairment (MoCA test, mean ±SD: 22.1±4.1 vs 
23.6±3.5, respectively; P=0.023, table 9) and a worse perception of physical health-related quality 
of life (SF-36 physical dimension score, mean ±SD: 41.8±7.1 vs 45±5.8, respectively; P=0.0057, 
table 9) than non-frails. 
 
Table 9 – Cognitive impairment (MoCA test, N=224) and health-related quality of life  
             (SF-36, N=218) according to frail phenotype. 
 
 
 Frail phenotype  
 Non-frail Pre-frail/frail P value 
Short form health survey (SF-36), N 218 
N of subjects (%) 173 (79.4) 45 (20.6)  
SF36 mental score 45.9 (9.5) 44.2 (10.4) 0.31 
SF36 physical score  45.0 (5.8) 41.8 (7.1) 0.0057 
Montreal Cognitive Assessment (MoCA) test, N 224 
N of subjects (%) 177 (79) 47 (21.0)  
Total score 23.7 (3.5) 22.1 (4.1) 0.023 
                                             Values are reported as means with standard deviation (±SD) 
                                              p values from non-parametric Wilcoxon Two-Sample Test (continuous)  
                                             Abbreviation: SF-36= Short form health survey; MoCA= Montreal Cognitive Assessment 
 
 
Pre-frail/frail individuals had lower levels of serum total cholesterol than non-frails (mean ±SD: 
185.6±38.9 vs 210±43.8 mg/dL, respectively; P=0.0004, table 10), which could be explained by the 




Table 10 –  Traditional markers of CVD risk (N=226). 
 
 Frail phenotype   
 Non-frail Pre-frail/frail P value 
N of subjects, (%)  176 (78.9) 47 (21.1)  
Total Cholesterol, mg/dL 210.0±43.8 185.6±38.9 0.0004 
HDL-Chol, mg/dL 58.2±13.0 57.4±15.7 0.90 
Triglycerides,  
mg/dL median (IQR) 
120 (92.5;161.5) 97 (82.0; 155.0) 
0.075 
HCL drug, (%) 29.0 43.2 0.10 
    
Glucose,  





    
MetS,% 40.3 48.9 0.32 
                    Values are reported as means with standard deviation (±SD) unless otherwise stated.  
                     p value from non-parametric Wilcoxon Two-Sample Test (continuous) and Exact Fischer test (categorical)  
                    Abbreviation: HCL=hypercholesterolemia;MetS=metabolic syndrome 
 
 
High blood levels of hs-CRP was found in pre-frails/frails as compared with no-frail elderly people 
(median (IRQ): 2.5 (1.0;4.8) vs 1.4 (0.8;3.5) mg/L, respectively; P=0.043, table 11). D-dimers 
plasma levels were also higher in pre-frails/frails compared to the non-frails (median (IRQ): 298 
(227;460) vs 254 (226;328) ng/mL, respectively; P=0.053, table 11). 
 
 
Table 11 – Biomarkers of inflammation and coagulation (N=226) 
 
 Frail phenotype 
 Non-frail Pre-frail/frail P value 
N of subjects, (%) 178 (78.4) 48 (21.6)  
C-Reactive Protein (mg/L), median (IRQ) 1.4 (0.8;3.5) 2.5 (1.0;4.8) 0.043 
Leukocyte count (×10
9
/L), median (IRQ) 5.9 (5.2;6.9) 5.4 (4.8;7.0) 0.24 
Granulocyte/lymphocyte ratio 2.00±0.99 2.14±0.94 0.42 
Platelet count (×10
9
/L) 236.2±53.3 236.7±69.0 0.93 
INFLA-score (-16 to 16) -0.086±5.24 0.63±7.20 0.63 
D-dimer (ng/mL), median (IRQ) 254 (226;328) 298 (227;460) 0.053 
             Values are reported as means with standard deviation (±SD) unless otherwise stated. 
              p value from non-parametric Wilcoxon Two-Sample Test 
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Chapter 5: Discussion  
In our population of elderly Southern-Italy subjects, overall prevalence of pre-frailty was 20.9% in 
women and 11.2% in men, and the prevalence of frailty was 7.3% in women and 3.5% in men. 
Despite the small sample, this is in line both with the Cardiovascular Health Study (CHS) by Fried 
LP et al. [2], which showed a prevalence of frailty in the original cohort (1989-1990) of 7.3% in 
females and 4.9% in males, and with Survey of Health, Ageing and Retirement in Europe – Frailty 
Instrument (SHARE-FI) study by Romero-Ortuno R et al. [261] in which the prevalence of pre-
frailty was 25.8% in women and 14.6% in men and the prevalence of frailty was 7.3% in female 
and 3.1% in male subjects. All these studies used the same instrument to measure frailty in the 
general population, confirming that the SHARE-FI represents a common language to evaluate 
frailty. As it currently stands, the main potential use of SHARE-FI is the screening and monitoring 
of frailty in the community or primary care setting in order to help decide who would benefit from 
secondary care referrals and/or early multidisciplinary case management. To that effect, the 
advantages of SHARE-FI are that it can be easily administered in the community by non-physicians 
(e.g. nurse, health visitor or other allied health professionals), and it is a brief instrument. If we 
consider the five components (exhaustion, weight loss, weakness, slowness and low activity) of the 
questionnaire individually, in this PhD work women experience more fatigue and have less 
handgrip strength. This result was also found in the study by Joosten E et al., in which the grip 
strength was higher in men than in women (23.1±9.8 vs 14.7±7.4 kg; P<0.001) in a sample of 209 
geriatric inpatients [275]. The fact that gender has a strongest influence on grip strength was also 
found in a multivariate linear regression analysis by Dudzińska-Griszek J et al. [276]. A recent 
systematic review investigating the prevalence of frailty [277] in 21 community based cohort 
studies, involving 61,500 older people found that, when the reported rates were restricted to the 
studies that used the phenotype model, the weighted average prevalence rate was 9.9% (95% 
Confidence Interval (CI) 9.6-10.2%) for frailty and 44.2% (95%, CI 44.2-44.7%) for pre-frailty. 
Moreover, frailty was statistically more prevalent in women (9.6%, 95% CI 9.2-10.0%) than men 
(5.2%, 95% CI 4.9-5.5%). Due to low number of frail persons in our study, for further analysis, pre-
frail and frail categories were collapsed to create a dichotomous variable having just two categories: 
“pre-frail/frail” vs “non frail” individuals. We found that frailty increased with age and was higher 
in women than men. Also in other studies frailty increased steadily with age, e.g.: 65-69 years: 4%; 




Rates appear to be higher in studies that employed the graded frailty index, which would count as 
frail some people whose increased risk is captured in the pre-frail category of the phenotype model 
[279]. Among the determinants of frailty, we can also include socio-economic status. As showed in 
our study, pre-frail/frail subjects had a lower level of education and household income. In scientific 
literature several studies reported that, for both men and women, adequacy of income was an 
independent determinant of frailty. This is compatible with the link between poverty and ill-health 
[280]. It is likely that frailty is an accompaniment of poorer health. Previous studies also suggested 
that socioeconomic factors contribute to differences in frailty and pre-frailty and that health 
inequalities as a result of education, occupational class, and wealth persist throughout old age 
[281,282]. Additionally, recent studies found an increased risk in the worsening of frailty over time 
in lower educated persons aged ≥55 years compared to higher educated persons [283-285]. This 
persisting inequality in old age can be partly explained by lifestyle and health, such as lower 
consumption of moderate amount of alcohol, higher sedentariness, higher obesity, higher chronic 
disease rates, and being depressed [286-290]. We know from the literature that there is a 
relationship between social factors and health. This relationship manifests itself in two ways. First, 
social integration (marriage, family relationships, friendships, church and civic communities, 
volunteering) is a good “therapy” for the health of the individuals because it prevents health 
problems, leads to more rapid recovery and extends life [291-293]. The more social relationships 
someone has, the fewer health problems they will suffer. This suggests that the onset of social 
frailty can lead to the onset or exacerbation of health problems. Older people with a low education 
level or a low income have a higher risk of mortality, being admitted to an institution and 
developing functional disabilities. These health differences among older persons suggest a 
systematic and chronic problem for the public health system, and indicate that the highest 
proportion of all health problems occurs in groups which are socially and economically 
underprivileged. If substantial socioeconomic differentials in frailty are found to exist among older 
persons, greater efforts need to be made to eliminate and reduce those differentials. In our study a  
higher prevalence of hypertension was found in pre-frail/frail elderlies, confirming previous 
evidence. Several studies, indeed, have assessed the association of frailty with hypertension, 
although the cause-effect relation is still debated. Four longitudinal studies examined the risk of 
incidence of frailty according to baseline hypertension status, providing conflicting results [294]. 
Two studies found that baseline hypertension did not significantly predict incidence of frailty 
[295,298], but Boullion K et al found that hypertension was associated with an increased incidence 
of the combined outcome prefrailty/frailty (P=0.009) [296].  
52 
 
Castrejón-Pérez RC et al. [297] found that hypertension was associated with incident frailty at 
univariate analysis (Hazard ratio (HR) 2.11, 95% CI 1.03 to 4.31), but this association was not 
confirmed in the multivariate analysis (HR 1.58, 95% CI 0.83 to 3.01). In older adults, it has been 
even suggested that frailty can explain the paradoxical relationship between lower blood pressure 
(BP) and increased mortality documented in several studies [366-369]; this could be the reason for 
which the higher hypertension prevalence is survived frail persons. For example, data from the 
National Health and Nutrition Examination Survey (NHANES) demonstrated an effect modification 
of hypertension according to frailty level in terms of walking speed [370]; in fit persons, elevated 
BP was associated with greater mortality, while in frail participants higher BP was associated with 
lower mortality risk. The Systolic Blood Pressure Intervention Trial (SPRINT) study showed that 
compared with standard BP control, intensive control reduces the incidence of cardiovascular 
events both in frail and non-frail persons, but this study did not show any effects of intensive BP 
control on risk of frailty-related outcomes, such as gait speed and mobility limitation [371,372]. The 
results of this PhD thesis showed that there is no difference in the Mediterranean diet (MD) 
adherence among non-frails and frails. However, consumption of individual food such as fruits, nuts 
and legumes was lower in pre-frail/frail elderlies. Our findings concur in part with those obtained in 
previous research [299,300]. Bollwein J et al. [299] conducted a cross-sectional study among 192 
community-dwelling older volunteers (>75 years) in Nürberg (Germany), who were classified into 
quartiles of the alternate MED score, developed from the original score of Trichopoulou et al. and 
adapted for a non-Mediterranean population. In multivariable analyses, the frequency of frailty, 
based on the Fried criteria [2], was significantly reduced in the highest quartile of the MED score 
[299]. In the Invecchiare in Chianti (InChianti) study, Talegawkar SA et al. [300] selected 690 
community-living persons aged ≥65 years in Tuscany (Italy), who were classified according to the 
MD score. Individuals were followed during 6 years to identify incident frailty, assessed with the 
Fried criteria [2] except for weight loss. After adjustment for confounders, higher adherence to a 
Mediterranean-style diet was associated with lower odds of developing frailty as compared with 
those with lower adherence. Although we did not find difference in the MD score, probably due to 
the low power of our study, our findings shows that the most important components of the MD may 
contribute to lower risk of frailty, namely legumes, fruits and nuts. Moreover, a significant tendency 
toward less frailty according to a high adhesion to the MD was observed in participants aged 65-69 
yeras; this probably reflects an interaction between the MD and subclinical diseases in the older 




The effect of a high dietary quality on frailty might be mediated by a high fruit and vegetable intake 
and low intake of animal products as proposed in the MED score. Furthermore, vegetable foods are 
the main nutritional sources of carotenoids and vitamin C. There is evidence that these associations 
are mediated by tissue damage caused by oxidative stress [303] and inflammatory processes 
[304,305]. This is supported by the finding that MD score is strongly associated with lower plasma 
concentrations of inflammation biomarkers in middle-aged and older people [306]. The assumption 
of anti-inflammatory effects of some components of the MD score is supported by the findings of 
Lopez-Garcia  E et  al. [307] who detected a dietary pattern characterized by higher intakes of fruit, 
vegetables, legumes, fish, poultry and whole grains that was inversely associated with plasma 
concentrations of inflammation markers. Poor nutrition might contribute to frailty, but on the other 
hand frailty might also affect dietary intake, for example by impairments in going shopping, 
chewing, or swallowing. Based on our data, it is not possible to decide, whether a Mediterranean 
diet prevents frailty or whether the diet is altered by frailty or comorbidity which might contribute 
to nutritional risk. Another limitation is the small sample size, and the small group of frail 
participants, which limits the statistical power to detect significant associations, which we 
nevertheless detected. A strong point of our study is that all European Prospective Investigation 
into Cancer and Nutrition – Food Frequency Questionnaires (EPIC-FFQs) have been conducted in 
personal interviews by a single experienced nutritionist. Secondly, for all assessments, well-
validated tools have been used, and professional personnel was engaged. In conclusion, our results 
are in line with existing evidence relating diet to frailty. About blood biomarkers inflammation, 
elevated levels of CRP and D-dimers were found in the frail elderly people of the Moli-sani Study. 
Higher hs-CRP levels were identified in the frail compared with the not frail group. In our 
study, as hs-CRP serum levels increased, D-dimers plasma levels also increased, so that 
the inflammatory/coagulation pathways have the potential to spiral into a self-perpetuating cycle, as 
several of the key factors feed back in a positive manner. For example, D-dimers are known to 
stimulate the synthesis and release of proinflammatory cytokines, including IL-6 form peripheral 
blood monocytes and mouse hepatic cells in vitro, as noted above [308,309]. IL-6 in turn, 
perpetuates the cycle by enhancing coagulation factor and platelet synthesis with microthrombi 
formation that, in turn, result in endothelial cell damage and further stimulation of both 
inflammatory and coagulation pathways. Thus, an increase in generalized thrombotic tendency seen 
in late life could be the result of the commonly acknowledged inflammatory dysregulation of aging. 
About biomerkers of CVD, we surprisingly found that total cholesterol serum levels were lower in 
pre-frail/frail people.  
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In an Italian study [310] the authors evaluated the association between serum cholesterol levels and 
social, clinical, and functional characteristics in 637 elderly hospitalized patients (mean age=79.1 
years, range = 65-97) from the Geriatric Evaluation and Rehabilitation Unit (GERU) at P. Richiedei 
Hospital in Gussago, Brescia (Italy). Patients consecutively admitted to the GERU during an 18-
month period underwent a multidimensional evaluation including information on demographics, 
cognitive status, physical health (number of chronic diseases and administered drugs), functional 
disability, and nutritional status. Mean cholesterol levels were significantly lower in men, persons 
living with others, older individuals, and individuals with cognitive impairment, poorer somatic 
health, higher disability, and a higher level of malnutrition. So that lower serum cholesterol levels 
may be considered an independent hematologic marker of frailty in elderly hospitalized patients 
[310]. In our case, low blood cholesterol levels were associated with the use of lipid-lowering 
drugs. In gene-specific models, which to some extent mimic the effects of long-term exposure of 
individuals to the modulation of lipid-lowering drug targets, most of the corresponding therapeutics 
(including statins) would be predicted to reduce frailty. A prospective cohort study of 383 residents 
aged ≥65 years found that the risk of mortality, all-cause hospitalizations, and incidence of falls 
during the 12-month follow-up were lower among statin users than non-users [311]. In contrast, an 
observational study of statin use and incident frailty in women aged ≥65 years failed to observe 
associations between current statin use, duration and potency of statin use and incident frailty. 
However, among users of low potency statins, longer duration of use was associated with reduced 
risk of frailty [312]. Our study was one of the few  investigating frailty and Mild Cogntive 
Impairment (MCI). Growing evidence has indicated that there is a connection between frailty and 
cognitive impairment. Several studies have reported a longitudinal association between frailty and 
rate of MCI in elderly community-dwelling individuals. Boyle PA et al. [230] reported, in an 
assessment that used 12 years of annual follow-up data, that physical frailty was associated with a 
high risk of MCI, such that each 1-unit (grip strength, timed walk, body composition, and fatigue) 
increase in physical frailty was associated with a 63% increase in the risk of MCI. Although the 
criteria for determining frailty and MCI varied lightly between studies, our results were in 
accordance with previous findings, and thus add support to the association between frailty and MCI. 
Despite some methodological differences, most previous studies report prevalence figures for MCI 
or for cognitive impairment without dementia ranging from 11% to 23%. The Women’s Cognitive 
Impairment Study of Exceptional Aging (WISE) used global and domain-specific cognitive 
measures and found that the prevalence of MCI or cognitive impairment without dementia was 
23.2% in a sample of 1,299 participants aged ≥85 years [313].  
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The Mayo Clinic Study of Aging (MCSA) diagnosed 329 of 1,969 study participants (16.7%) with 
MCI or cognitive impairment without dementia using the Clinical Dementia Rating (CDR) Scale, a 
neurologic evaluation, and neuropsychological testing to assess 4 cognitive domains: memory, 
executive function, language, and visuospatial skills [314-315]. In the present study, we found the 
combined prevalence of frailty and MCI using Montreal Cognitive Assessment (MoCA) test and 
Short Form Health Survey (SF-36) self-administered questionnaire. MoCA test, and a state of low 
physical and mental health perceived by the subject through SF-36 questionnaire. These results 
suggest that frailty is linked to both conditions. Many researchers believe that the definition of 
frailty should include mental health as well as physical functioning. The Frailty Operative 
Definition – Consensus Conference (FOD-CC) project reported that experts agreed on the 
importance of a more comprehensive definition of frailty that should include assessment of physical 
performance, including gait speed and mobility, nutritional status, mental health, and cognition 
[17]. The results of the present study are in line with the new concept of frailty, which included 
cognition. Individuals with a co-occurrence of frailty and MCI may face a higher risk of incident 
disability than healthy older adults or older adults with either frailty or MCI. The French Three-City 
Study established that frail persons with a cognitive impairment were significantly more likely to 
develop disabilities in activities of daily living (ADL) and instrumental ADL (IADL) disabilities 
[316]. Moreover, the Hispanic Established Populations for the Epidemiologic Study of the Elderly 
(HEPESE) demonstrated that frailty and cognitive impairment affect mortality differently when 
they occur independently compared with when they are present together. For instance, individuals 
with cognitive impairment and frailty had higher mortality compared with individuals with either 
frailty or cognitive decline [317]. Further longitudinal studies are needed to clarify the ways in 










Chapter 6: Conclusions 
Frailty is a practical and unifying concept in the care of older people that directs attention away 
from organ specific diagnoses towards a more holistic viewpoint of the patients and their 
predicament. It is a state of vulnerability to poor resolution of homeostasis following a stress and is 
strongly associated with adverse outcomes. Distinguishing older people who are frail from people 
who are not frail should therefore form an essential aspect of assessment in any health care 
encounter that might result in an invasive procedure or potentially harmful medication. Preventing 
frailty and its consequences is a challenge to an aging society, and there are important obstacles to 
such prevention. One is the need for a more precise characterization of the clinical syndrome of 
frailty and its natural history. Multiple, interacting diseases are common in frailty; the prevalence of 
such comorbidity increases as disability increases, but it is unclear how this relation should be 
interpreted. For example, some diseases (e.g. stroke, myocardial infarction, renal failure) may have 
similar mechanisms and may all be expressed as frailty. Likewise, frailty may be a final common 
path in the expression of unrelated diseases. In either event frailty may be merely a state through 
which many elderly people pass toward the end of life. Interventions should be targeted to the frail, 
and the evaluation of them should focus on the consequences of frailty. This PhD study provides a 
comprehensive overview of the components of frailty within several domains: nutritional, physical, 
psychological, social and biochemical. Although consensus on frailty measures remains elusive, this 
research describes the most commonly used frailty components and the corresponding indicators in 
contemporary publications. These findings can be used to guide the development of a theoretical 
framework of frailty in future studies. Clinicians can use these frailty components and their 
corresponding indicators to comprehensively identify frail older adults from physical, psychological 
and social perspectives to provide holistic care to meet the multidimensional healthcare needs of 
this vulnerable population. We used the Survey of Health, Ageing and Retirement in Europe – 
Frailty Instrument (SHARE-FI), because it is a simple frailty screening instrument for primary care, 
it has sufficient constructand predictive validity, and it is readily and freely accessible via web 
calculators. Inadequate nutritional intake is frequent among older people and related to increasing 
dependence and care needs. The association between poor nutritional intake and frailty was 
demonstrated in numerous recent studies. Not only energy and protein intake has been linked to 
frailty and frailty-related parameters. Particularly the role of micronutrients in the developmentof 




Micronutrient intake has been found to be associated with frailty or related parameters of physical 
functioning, sometimes even independent from energy intake. In clinical practice and as part of the 
management of aging it should therefore be recommended to use a suitable tool for routine 
screening of nutritional risks. Consequently, the goal will be to raise the general dietary intake of 
high-quality food to provide sufficiently both macro and micronutrients. We found that adherence 
to Mediterranean Diet (MD) components was associated with lower risk of frailty. Although 
consumption of fruit, legumes and nuts showed a reduced risk of frailty, we can say that the 
association between MD and frailty is mostly due to the global dietary pattern instead of single 
foods. In the future, clinical trials should evaluate whether an intervention promoting MD is able to 
prevent frailty with its anti-inflammatory effect. There are several potential mechanisms underlying 
the association between greater adherence to a Mediterranean diet and lower risk of frailty. One 
possibility is the high intake of foods rich in antioxidants. Fruits and vegetables are rich in 
carotenoids, vitamins, and polyphenols. Oxidative stress is a risk factor for frailty and fruits and 
vegetables may decrease the risk of frailty by counteracting oxidative status. Frail individuals have 
higher levels of inflammatory markers, and inflammation is considered to be closely associated with 
frailty. A frequent intake of nuts has been associated with decreased levels of IL-6, CRP and 
fibrinogen and MD is associated with low levels of inflammatory markers and may reduce frailty 
risk through this mechanism. The fact that these beneficial effects are observed in old frail subjects 
suggests that it is never too late to change dietary habits for improving health status. Adherence to a 
MD pattern has been associated with better cognitive function, lower rates of cognitive decline, and 
lower risks of Alzheimer’s disease and dementia. Both frailty and cognitive impairment are very 
common among nonagenarians and centenarians. The combined syndrome, and not frailty or 
cognitive impairment alone, is a significant risk factor among elderly people. This study evidenced 
the association between frailty and cognitive impairment. This topic is very recent and deserves 
further research in epidemiological and clinical studies. In addition, the data may support the debate 
and the elaboration of public policies focused on frailty syndrome and cognitive impairment, in 
order to deal with the demographic growth of the country and the higher life expectancy of the 
population. Moreover, it is the first study in which the Short Form Health Survey (SF-36) 
questionnaire was used to study the mental and physical health perceived by the same recruited 
subject with surprising results associated with frailty syndrome. Based on the results of studies in 
the scientific literature, we can also presume that depression mediates the relation between frailty 
and cognition, or inflammatory reactions. Because frailty is related to cognitive aging, several 




Although experts disagree on the core underlying processes involved, one factor that links many 
factors associated with cognitive aging is neuroinflammation. Markers of inflammation are 
associated directly with deficits in cognitive function and with diseases that are risk factors for 
cognitive decline. Neuroinflammation is also associated with depression and may account for the 
complex interaction of depression and cognition in older adults. Interventions that reduce 
inflammation may improve cognition. Understanding how neuroinflammation affects cognition may 
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